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ABSTRACT 
DEVELOPMENT OF BICLUSTERING TECHNIQUES FOR GENE EXPRESSION 
DATA MODELING AND MINING 
JUAN XIE 
2018 
The next-generation sequencing technologies can generate large-scale biological 
data with higher resolution, better accuracy, and lower technical variation than the array-
based counterparts. RNA sequencing (RNA-Seq) can generate genome-scale gene 
expression data in biological samples at a given moment, facilitating a better 
understanding of cell functions at genetic and cellular levels. The abundance of gene 
expression datasets provides an opportunity to identify genes with similar expression 
patterns across multiple conditions, i.e., co-expression gene modules (CEMs). Genome-
scale identification of CEMs can be modeled and solved by biclustering, a two-
dimensional data mining technique that allows clustering of rows and columns in a gene 
expression matrix, simultaneously. Compared with traditional clustering that targets 
global patterns, biclustering can predict local patterns. This unique feature makes 
biclustering very useful when applied to big gene expression data since genes that 
participate in a cellular process are only active in specific conditions, thus are usually co-
expressed under a subset of all conditions. 
The combination of biclustering and large-scale gene expression data holds 
promising potential for condition-specific functional pathway/network analysis. 
However, existing biclustering tools do not have satisfied performance on high-resolution 
xii 
 
RNA-Seq data, majorly due to the lack of (i) a consideration of high sparsity of RNA-Seq 
data, especially for scRNA-Seq data, and (ii) an understanding of the underlying 
transcriptional regulation signals of the observed gene expression values.  QUBIC2, a 
novel biclustering algorithm, is designed for large-scale bulk RNA-Seq and single-cell 
RNA-seq (scRNA-Seq) data analysis. Critical novelties of the algorithm include (i) used 
a truncated model to handle the unreliable quantification of genes with low or moderate 
expression; (ii) adopted the Gaussian mixture distribution and an information-divergency 
objective function to capture shared transcriptional regulation signals among a set of 
genes; (iii) utilized a Dual strategy to expand the core biclusters, aiming to save dropouts 
from the background; and (iv) developed a statistical framework to evaluate the 
significances of all the identified biclusters. Method validation on comprehensive data 
sets suggests that QUBIC2 had superior performance in functional modules detection and 
cell type classification.  The applications of temporal and spatial data demonstrated that 
QUBIC2 could derive meaningful biological information from scRNA-Seq data. 
Also presented in this dissertation is QUBICR.  This R package is characterized 
by an 82% average improved efficiency compared to the source C code of QUBIC. It 
provides a set of comprehensive functions to facilitate biclustering-based biological 
studies, including the discretization of expression data, query-based biclustering, bicluster 
expanding, biclusters comparison, heatmap visualization of any identified biclusters, and 
co-expression networks elucidation. 
In the end, a systematical summary is provided regarding the primary applications 
of biclustering for biological data and more advanced applications for biomedical data. It 
xiii 
 
will assist researchers to effectively analyze their big data and generate valuable 
biological knowledge and novel insights with higher efficiency.               
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CHAPTER 1: Introduction 
1.1 Gene Expression Data 
Gene expression is the process by which information from a gene is used in the 
synthesis of a functional product, that is, a molecule needed to perform a job in the cell 
(e.g., protein). The process mainly consists of two steps: transcription and translation. In 
transcription, the DNA sequence of a gene is copied to make an RNA molecule. In 
translation, the sequence of the mRNA is decoded to specify the amino acid sequence of 
a polypeptide. Since genes encode proteins and proteins dictate cell functions, the genes 
expressed in a cell determine what the cell can do. 
Many biotechnologies are available to profile gene expression. Microarrays 
emerged in the late 1990s, which is the first high-throughput technology that enables the 
researchers to monitor the expression level of tens of thousands of genes simultaneously  
[1]. Microarrays are typically microscope slides that are printed with thousands of tiny 
spots in ordered positions, with each spot containing a known DNA sequence or gene. 
After steps of mRNA extraction, cDNA synthesis, cDNA fragmentation, and fluorescent 
labeling, the relative abundance of genes is quantified by detecting fluorescent intensity, 
which is continuous and positive.  Due to its easy accessibility and low cost, microarrays 
have been the most widely used platforms in generating gene expression.  However, 
microarrays need a reference genome and transcriptome to be available; thus, their 
application is confined to organisms whose genome have already been sequenced. 
 With the advent of massively parallel sequencing, next-generation sequencing 
(NGS) technologies have become more affordable. Compared to the array-based 
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counterparts, NGS has higher resolution, better accuracy, lower technical variation and 
many other advantages [2, 3].  It allows for a much faster-paced accumulation of large-
scale biological data. The high-throughput RNA-sequencing (RNA-Seq) is a 
revolutionary technology for gene expression profiling and promises a comprehensive 
picture of the transcriptome for a biological process [4, 5]. Unlike microarrays, RNA-Seq 
can be used to new organisms whose genome has not been sequenced yet. It extracts 
usable information from the mature mRNA within a biological source and generates a 
massive number of short segments (reads, 100-250 bps), which enable the discrete 
quantification of all genes expressed in a cell [5, 6].  Currently, researchers can either 
analyze a large sample of cells from a single organism in the form of bulk RNA-Seq data 
or isolate individual cells from complex organisms and measure their transactional 
activity through single-cell RNA-sequencing (scRNA-Seq). Such gene expression data 
from individual cells promises to provide a better understanding of cell functions at 
genetic and cellular levels[7] . In short, these biotechnologies have generated large 
genome-scale gene expression data in the public domain, and their tremendous values 
have been confirmed in many research areas such as elucidation of cell-type-specific 
regulatory networks [8, 9] and cancer & complex diseases studies [10-12].  
1.2 Biclustering Techniques 
The abundance of gene expression datasets provides an opportunity to identify 
genes with similar expression patterns across multiple conditions, i.e., co-expression gene 
modules (CEMs). The genes in these modules tend to be functionally related or co-
regulated by the same transcriptional regulatory signals (TRSs). Thus, they enable the 
higher-level interpretation of gene expression data, improve functional annotation, 
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facilitate inference of gene regulatory mechanisms, and are useful for a better 
understanding of disease/cancer mechanisms. Genome-scale identification of CEMs can 
be modeled and solved by biclustering [13], which was introduced by Hartigan in 1972 
[14] and applied to gene expression data analysis by Cheng and Church in 2000 [15]. 
Biclustering is a two-dimensional data mining technique that allows clustering of rows 
(representing genes) and columns (representing samples/conditions) in a gene expression 
matrix, simultaneously. The biclustering method can capture biologically meaningful and 
computationally significant CEMs, by identifying (possibly overlapped) homogeneous 
submatrices, subsets of rows with a coherent pattern across subsets of columns that satisfy 
specific quality metrics (e.g., mean squared residue used in [15] and MSE used in [16]). 
This unique feature makes it very useful when applied to big gene expression data since 
genes that participate in a cellular process are only active in specific conditions, thus are 
usually co-expressed under a subset of all conditions.  
Besides the identification of CEMs, scRNA-Seq data enables studies of individual 
cells or cell types as well as their complex interactions under specific stimuli, e.g., cell 
types classification and clustering. In multicellular organisms, biological function emerges 
when various cell types form complex organs [17]. Investigations into organ development, 
cell function, and disease mechanisms highly depend upon accurate identification and 
categorization of cell types, sometimes along with their temporal and spatial features [18]. 
Traditionally, cell type was defined based on morphological properties or marker proteins, 
yet this method failed to characterize the full diversity of cells. scRNA-Seq data provides 
the possibility to group cells based on their genome-wide transcriptome profiles, and 
several studies have already been carried out using scRNA-Seq data to identify novel cell 
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types, proving its power to unravel the full diversity of cells in human and mouse [8]. 
Mathematically, the problem of cell types classification can be treated as biclustering 
problems, as the essence is to find sub-populations of cells sharing common expression 
patterns among subsets of genes. 
A substantial number of biclustering methods were developed during the past 18 
years [15, 16, 19-36]. SAMBA [28], ISA [29], Bimax [30], QUBIC [31], and FABIA [37] 
are some popular algorithms for general purpose. CCC-biclustering [38-40] is designed for 
temporal data analysis, and BicPAM [41], BicNET [35, 42] and MCbiclust [43] are three 
recent studies.  Besides, several tools (R packages, web servers, etc.) have been developed 
to facilitate users with a limited computational background [23, 44-50]. GEMS [47] is a 
web server for gene expression mining based on a Gibbs sampling paradigm; and biclust 
[48] and QUBICR [49] are two R packages integrating multiple existing algorithms, data 
preprocessing functions, and interpretation & visualization of the results. A list of some 
highly cited or recently published biclustering algorithms and tools is shown in Table1. 
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Table 1. Summary of biclustering algorithms and tools, sorted in the decreasing order of their numbers of citation since published. 
Application or usage was noted for some of the algorithms. Citations were collected via Google Scholar as of Sep 2018 
Algorithms/ 
Tools 
Citations* Published 
Year 
Review comments* Notes 
SAMBA [28] 939 2002 - - 
Bimax[30] 874 2006 E Choice for constant-upregulated biclusters - 
ISA [29] 414 2002 E Choice for constant-upregulated biclusters; 
NC Performs well on synthetic data 
- 
Plaid[16] 717 2002 E Choice for constant-upregulated biclusters; 
Has the highest enriched bicluster ratio in 
real datasets 
 
Spectral[51] 654 2003 NC Performs well on human and synthetic 
data 
 
cMonkey[52] / 
cMonkey2 [53] 
257/ 
21 
2006/ 
2015 
- Integrates various orthogonal pieces 
of information which support 
evidence of gene co-regulation, and 
optimizes biclusters to be supported 
simultaneously by one or more of 
these prior constraints 
FABIA [32] 198 2010 E Choice for constant-upregulated biclusters;  
NC Performs well on synthetic data 
- 
SSVD [54] 192 2010 - - 
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QUBIC [31] 167 2009 E Choice for constant-upregulated 
biclusters; Has the highest enriched 
bicluster ratio in real datasets 
NC Performs well on synthetic and human 
data 
 
BBC[55] 126 2008 E Best one for plaid biclusters - 
CPB[56] 40 2009 E Best one for constant, scale, shift and 
shift-scale datasets 
 
LAS [57] 113 2009 - Discovery of biologically relevant 
structures in high dimensional data; 
Significant results highlighted with 
a large negative average image for 
easy observation. 
BackSPIN [58] 830 2015 - First biclustering algorithm for 
scRNA-Seq data 
PPA [59] 93 2008 - - 
CCC-Biclustering [60] 95 2010 - Coherent biclusters with maximal 
contiguous columns in linear time; 
Combining time-series expression 
with the regulatory network. 
COALESCE [61] 80 2009 E Choice for constant-upregulated biclusters Efficient enough to discover 
expression biclusters and putative 
regulatory motifs in metazoan 
genomes and very large microarray 
compendia (>10,000 conditions) 
BioNMF [62] 79 2006 - - 
BiGGEsTs [39] 51 2009 - Suitable for temporal biclustering 
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 Note: In the Reviewer Comments column, algorithms/tools mentioned by [69] are denoted by ‘E’, mentioned by [70] are denoted by ‘NC’ 
NCIS [63] 44 2014 - Identification of cancer subtypes 
FD-MSCM [64] 35 2010 - - 
BicPAM [41] 28 2014 - Biclustering for biomedical data 
analysis; 
Suitable for non-constant biclusters 
IBBiG [65] 24 2012 - - 
BUBBLE [66] 14 2006 - Based on bottom-up search strategy; 
Using mean squared residue 
measurement. 
SparseBC [67] 21 2014 - - 
BicNET [35] 13 2016 - Discovery of non-trivial modules 
directly for biological network 
construction; 
Noisy and missing interaction fix; 
Analysis of protein interaction and 
gene interaction networks 
MCbiclust [68] 3 2017 - - 
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Several review studies of biclustering have been carried out in different 
perspectives [30, 71-75]. For example, Pontes et al. presented a taxonomy of 47 
biclustering algorithms according to their search strategies [76], and Busygin et al. 
emphasized the mathematical models and concepts in biclustering techniques [77]. Padilha 
et al. claimed that an algorithm only achieved satisfactory results in a specific context and 
the best choice depends on particular objectives [74]. Eren et al. compared 12 popular 
algorithms and concluded that QUBIC is one of the best as it achieves the highest 
performance in synthetic datasets and captures a high proportion of enriched biclusters on 
real datasets, and Plaid, FABIA, ISA and Bimax are the recommended tools for capturing 
upregulated biclusters [78]. Adetayo et al. presented an overview of data analysis using 
biclustering methods from a practical point of view, accompanied by R examples [79]. In 
2018, Saelens et al. ranked Spectral, ISA, FABIA and QUBIC as the top biclustering 
methods regarding predicting gene modules from human and/or synthetic data [70].    
1.3 QUBIC 
 QUBIC (Qualitative BIClustering algorithm) is a qualitative biclustering 
algorithm, which was first introduced in 2009.  It assumes that a gene has three 
expression states under all the conditions, i.e., highly-expressed, lowly-expressed, and 
normally-expressed. The values in the first two expression states are so-called affected 
values. QUBIC employs a framework to identify dynamic cutoffs and corresponding 
affected values for different genes (Figure 1). A discretized qualitative matrix (MR) can 
be generated after applying the above process to each gene, with non-zero integers 
representing affected values and 0s being background. Then a weighted graph is 
constructed based on this matrix, where each node corresponds to a gene, and each edge 
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has a weight indicating the similarity level between the two corresponding genes. The 
aim is to search biclusters corresponding to induced heavy subgraphs, which is an NP-
hard problem. QUBIC heuristically iterates a seed list (S), where a seed represents a pair 
of genes, and its weight is the number of conditions under which they have the same 
values in MR. In each iteration, it starts from a feasible seed with the highest weight, then 
expands vertically and horizontally to recruit more genes and conditions. Finally, QUBIC 
outputs a bicluster with max (min (I, J)), where I and J being the number of rows and 
columns of the bicluster (Figure 1). 
 
 
1 … 1 … -1 … -1 … 1
1 … 1 … -1 … -1 … 1
7.6 6.0 7.3 8.3 9.1 8.7 7.4 6.4 9.2 6.5 8.1 7.2 8.4 8.9 8.8 6.5
1 -1 0 1 1 1 0 0 1 -1 1 0 1 1 1 -1
1 … 1 … -1 … -1 … 1
1 … 1 … -1 … -1 … 1
1 … 1 … -1 … -1 … 0
1 … 1 … -1 … -1 … 1
1 … 1 … -1 … -1 … 1
1 … 1 … -1 … -1 … 0
1 … 1 … -1 … -1 … 0
min{I,J}=2
min{I,J}=3
min{I,J}=4
Reach max(min(I,J)),
Output
ML UU’
-1 0 1
C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 C16
G1 1 -1 0 1 1 1 0 0 1 -1 1 0 1 1 1 -1
G2 1 -1 1 1 1 1 0 1 1 0 1 -1 1 0 1 0
… 1 0 1 0 -1 1 -1 1 0 1 1 -1 1 0 1 1
U’- M = M- L
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Figure 1. Workflow of QUBIC. QUBIC sorts the expression values of the gene i under all given 
conditions in an increasing order: 𝑣𝑖1⋯𝑣𝑖,𝑠−1𝑣𝑖𝑠 ⋯𝑣𝑖,𝑐−1𝑣𝑖𝑐𝑣𝑖,𝑐+1⋯𝑣𝑖,𝑚−𝑠+1𝑣𝑖,𝑚−𝑠+2⋯𝑣𝑖𝑚 , 
where c=m/2 and s-1= m×q (q=6% by default). Then it selects initial bounds L= 𝑣𝑖,𝑠−1 and U= 
𝑣𝑖,𝑚−𝑠+1. QUBIC adjusts the bounds based on their distance from the median (M= 𝑣𝑖𝑐), e.g., if 
(U-M) > (M-L), then use U’ = (M-L) + M = 2M –L as the new upper bound. The values less or 
equal to L are labeled as -1, those greater or equal to U’ are labeled as 1, and those fall between L 
and U’ are labeled as 0. Repeat this process for each gene in the dataset, a representing matrix MR 
can be generated. 
 
1.4 Qserver 
QUBIC has been proved to be able to solve more general biclustering problems 
than previous biclustering algorithms[31]. To fully utilize the analysis power of QUBIC, 
a web server named Qserver (Qualitative BIClustering server) was developed in 
2011[23]. Qserver integrates capabilities of biclustering with cis-regulatory motifs 
prediction and functional enrichment analyses. Specifically, Qserver provides the 
following functionalities: (i) biclustering analysis using QUBIC; (ii) prediction and 
assessment of conserved cis-regulatory motifs in promoter sequences of the predicted co-
expressed genes; (iii) functional enrichment analyses of the predicted co-expressed gene 
clusters using Gene Ontology (GO) terms, and (iv) visualization capabilities in support of 
interactive biclustering analyses.  
For biclustering analysis, QUBIC algorithm is implemented. Users can provide 
continuous or discretized gene expression matrix as input. If continuous data is provided, 
Qserver will automatically discretize it qualitatively. Qserver allows users to adjust the 
main parameters in QUBIC, and suggestion regarding how to change for different 
applications is provided in the Help page.  
11 
 
After obtaining sets of biclusters, QServer allows computationally validating of 
the biclusters by predicting conserved cis-regulatory motifs among the promoter 
sequences automatically extracted from the upstream sequences (the default value is 300 
bps long) of the co-expressed genes. Two motif prediction programs, BOBRO [80] and 
MEME[81] are provided,  both of which attempt to find conserved sequences among a 
set of given promoter sequences using different strategies, and both offer a statistical 
significance score for each predicted motif.   
For the predicted biclusters, Qserver can also conduct functional enrichment 
analysis based on GO classification. Specifically, given a bicluster, Qserver will check if 
it is enriched with a GO term, compared against the background gene distribution, i.e., 
the whole genome. A P-value and enrichment ratio of that GO term will be provided.  
It is common that different sets of gene expression data may use different naming 
conventions for genes. To deal with this issue, Qserver collected three gene/protein 
naming systems (i.e., GI, locus, and RefSeq) so that it can automatically detect the 
naming system used in an expression matrix. It also collected the genome sequences and 
the gene annotations from the NCBI Genome database in support of motif prediction and 
functional enrichment analysis, covering human, mouse, Arabidopsis, B subtilis, 
Synechocystis sp. PCC6803, Synechococcus sp. WH8102 and E. coli K12. For other 
organisms, Qserver will only do biclustering analysis and plot the heatmaps for 
biclusters.  
In summary, Qserver provides three functional modules for the expression data. 
First, the input matrix is subject to biclustering analysis using QUBIC.  For each 
bicluster, cis-regulatory motifs are then identified in the promoter regions of its 
12 
 
component genes, using either MEME or BOBRO. Qserver will also provide the detailed 
information of each identified motif, including its P-value and the logo plot. The third 
module is to identify enriched GO categories among genes in each bicluster. The 
workflow of Qserver is shown in Figure 2.  
 
Figure 2. An example workflow of using Qserver. 
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CHAPTER 2: QUBIC2—A Novel Biclustering Algorithm for Large-scale RNA-Seq 
Data Analysis 
Although numerous algorithms and tools have been developed for gene 
expression data analysis, most existing biclustering algorithms are designed and 
evaluated using microarray rather than RNA-Seq data. One of the unique features of gene 
expression data derived from RNA-Seq, especially the scRNA-Seq data, is the massive 
zeros (up to 60% of all the genes in a cell have read counts being zeros) [82, 83]. The 
normalized read counts roughly follow lognormal distributions; however, the raw zero 
counts of specific genes will lead to negative infinity after logarithmic transformation 
[84-87], resulting in unquantifiable errors. Therefore, the biclustering methods that are 
successful for microarray cannot be directly applicable to RNA-Seq data [88], and novel 
methods taking full consideration of characteristics of RNA-Seq data are urgently needed 
in the public domain. In this chapter, I will present QUBIC2, a novel biclustering 
algorithm developed for large-scale RNA-Seq data analysis. 
2.1 Overall Design of QUBIC2 
Inheriting the qualitative representation and graph-theory based model from 
QUBIC [31], QUBIC2 has four unique features: (i) developed a rigorous truncated model 
to handle the unquantifiable errors caused by zeros, and used a reliable qualitative 
representation of gene expression to reflect expression states corresponding to various 
TRSs; (ii) integrated an information-divergence objective function in the biclustering 
framework in support of functional gene modules identification; (iii) employed a Dual 
strategy to expand the cores, aiming to save dropouts from the background.; and (iv) 
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developed a robust P-value framework to support statistical evaluation of all the 
identified biclusters. Details of these four features are showcased as follows. 
A mixture of left-truncated Gaussian distributions (LTMG) model was designed to 
fit the RNA-Seq data, rather than discarding zeros or adding a small constant to original 
counts [85, 89]. The basic idea is to treat the large number of observed zeros and low 
expressions as left censored data in the mixture Gaussian model of each gene [90, 91], 
assuming that the observed frequency of expressions on the left of the censoring point 
should be equal to the area of the cumulative distribution function of the mixture Gaussian 
distribution left of the censoring point. Furthermore, we assumed that a gene should receive 
𝐾 possible TRSs under all the conditions, and its expression profile would follow a mixture 
of 𝐾  left truncated Gaussian distributions. The LTMG model was applied to fit the 
expression value of each gene, and the gene expression value under a specific condition 
was labeled to the most likely distribution. Accordingly, a row consisting of discrete values 
(1,2, ⋯, 𝐾) for each gene was generated (Figure 3A). Then this qualitative row was split 
into 𝐾 new rows, such that in the 𝑖th row those previously labeled as 𝑖 are labeled as 1, 
while the rest were labeled as 0.  Finally, a binary representing matrix MR was generated. 
A weighted graph 𝐺 = (𝑉, 𝐸)  was constructed based on MR, where nodes 𝑉 
correspond to genes, edges 𝐸 connecting every pair of genes (Figure 3B). The edge weight 
indicates the similarity between the two corresponding genes, which is defined as the 
number of conditions in which the two genes have 1s in MR. Intuitively, two genes from a 
bicluster should have a heavy edge in 𝐺 innately while two random genes may have a 
heavy edge only accidentally. Hence, a bicluster should correspond to a maximal subgraph 
of 𝐺, with edges typically heavier than the edges of an arbitrary subgraph. Identifying all 
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the biclusters equals to identifying all the heavy subgraphs in 𝐺, which is an NP-hard 
problem. Therefore, a heuristic strategy was designed as follows.  
Figure 3. QUBIC2 workflow. A. Discretization of gene expression data. Each gene’s expression 
profile is fitted by the LTMG model and discretized qualitatively. Finally, a binary representing 
matrix is generated; B. Graph construction and seed selection. A weighted group is constructed 
based on the representing matrix. Then a feasible seed is selected from the seed list; C. Build an 
initial core based on the seed. QUBIC2 will recruit genes with higher weight with the seed. If two 
genes have the same weight, the one with higher KL score will be selected; D. Expand core and 
determine pool. QUBIC2 will expand the core vertically and horizontally to recruit more genes 
and conditions, respectively. The intersected zone created by extended genes and conditions as a 
Dual searching pool; E. Dual search in the pool and output the bicluster with genes and 
conditions that come from Core and Dual as final bicluster (red box); F. Statistical evaluation of 
identified biclusters based on either biological annotations or the size of the bicluster. 
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The algorithm would iterate a seed list (𝑆), which is the sorted list of edges in 𝐺 in 
the decreasing order of their weights (i.e., 𝑤(𝑒1) ≥ 𝑤(𝑒2) ≥ ⋯ ,𝑤(𝑒 𝐸 ) ). An edge 𝑒𝑖 =
 𝑖   is selected as a seed if and only if at least one of  𝑖 and    is not in any previously 
identified biclusters, or   𝑖 and    are in two nonintersecting biclusters in terms of genes. 
QUBIC2 first built a core bicluster from a seed and then expanded to recruit more genes 
and conditions into a to-be-identified bicluster, until the Kullback-Leibler divergence score 
(KL score) was locally optimized. It was proposed based on the assumption that the 
difference between a bicluster and its background should be larger than the difference 
between an arbitrary same-size submatrix and its background. The KL score of a bicluster 
was designed to quantify this difference as the larger of the difference was, the larger of 
the score is (Figure 3C. See Section 2.2.2 for details). 
The previous steps predict an all-1 core. We believe that some 0s outside the cores 
are dropouts and therefore we need to expand the cores. Since it is difficult to determine 
the cutoffs for expansion, we first expand the core both horizontally and vertically, and 
then heuristically search another core in the expanded region. Specifically, during 
expansion, the algorithm will control the consistency level for a bicluster, which is defined 
as the minimum ratio of the number of 1s in a column/row and the number of rows/columns 
in the bicluster. Then QUBIC2 will adopt the same strategy as it used for predicting Cores 
to search another core in the expanded region (Figure 3D-E), giving rise to a submatrix (I, 
J) of MR (i.e., a bicluster) with optimized consistency level and maximal KL score can be 
identified. It is assumed that 0s induced in this way are more likely to be dropouts. 
Furthermore, for the first time, a statistical framework based on the size of the 
biclusters was implemented to calculate a P-value for each of the identified biclusters. The 
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problem of assessing the significance of identified biclusters was formulated as calculating 
the probability of finding at least one submatrix enriched by 1 from a binary matrix with 
given size, with a beta distribution employed during the process. This P-value framework 
enables users systematically evaluate the statistical significance of all the identified 
biclusters, especially for those from less-annotated organisms (Figure 3F). 
2.2 Detailed Methods in QUBIC2 
2.2.1 Left Truncated Mixed Gaussian (LTMG) Model and Qualitative Representation 
To accurately model the gene expression profile of RNA-Seq and scRNA-Seq 
data, we explicitly developed a mixed Gaussian model with left truncation assumption. 
Denotes the log-transformed FPKM, RPKM or CPM expression values of gene X over 𝑁 
conditions as X = {𝑥1,𝑥 }, we assumed that 𝑥  𝑋 follows a mixture of 𝑘 Gaussian 
distributions, corresponding to 𝑘 possible TRSs. The density function of 𝑥  is: 
𝑝 𝑥 ; Θ = ∑𝛼𝑖𝑝(𝑥 ; 𝜃𝑖)
 
𝑖=1
= ∑𝛼𝑖
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√2𝜋𝜎𝑖
𝑒
− 𝑥𝑗−𝜇𝑖 
2
2𝜎𝑖
2
 
𝑖=1
 
And the density function of X is: 
𝑝(X;Θ) = ∏𝑝(𝑥 ; Θ)
 
 =1
= ∏∑𝛼𝑖𝑝(𝑥 ; 𝜃𝑖)
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𝑖=1
 
 =1
= 𝐿(Θ;𝑋) 
where 𝛼𝑖  is the mixing weight,  𝜇𝑖  and 𝜎𝑖  are the mean and standard deviation of i
th 
Gaussian distribution, which can be estimated by the EM algorithm with given X: 
Θ∗ =        Θ
argmax 𝐿(Θ;𝑋)
 
To model the errors at zero and the low expression values, we introduce a 
parameter 𝑍𝑐𝑢𝑡  for each gene expression profile and consider the expression values 
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smaller than 𝑍𝑐𝑢𝑡 as left censored data. With the left truncation assumption, the gene 
expression profile is split into 𝑀 truly measured expression value (> 𝑍𝑐𝑢𝑡) and 𝑁 −𝑀 
left censored gene expressions (≤𝑍𝑐𝑢𝑡) for the 𝑁 conditions. Latent variables 𝑦  and 𝑍  
are introduced to estimate Θ by the following Q function: 
𝑄(Θ; Θ𝑡−1) = ∑𝑝 𝑦 |𝑥 ; 𝛩
𝑡−1 ∑ ∑log (𝛼𝑖𝑝(𝑥 ; 𝜇𝑖, 𝜎𝑖)
 
𝑖=1
)
𝑚
 =1
+∑𝑝 𝑦 |𝑧 ; 𝛩
𝑡−1 ∑  ∑log (𝛼𝑖𝑝(𝑧 ; 𝜇𝑖 , 𝜎𝑖)
 
𝑖=1
)
 
 =𝑚+1
 
To estimate the parameters Θ that maximizes the likelihood function, we have 
Maximization step of the EM algorithm as [92]:  
𝑎𝑖
𝑡 =
1
𝑁
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𝑡−1 
𝑀
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where 𝑃 𝑖|𝑍 , 𝑍𝑐𝑢𝑡, Θ
𝑡−1 =
𝑃(−∞<𝑍𝑗<𝑍𝑐𝑢𝑡 𝑢𝑖
𝑡−1,𝜎𝑖
𝑡−1)
∑ 𝑃(−∞<𝑍𝑗<𝑍𝑐𝑢𝑡 𝑢𝑖
𝑡−1,𝜎𝑖
𝑡−1)𝐾𝑖=1
, 𝐻(𝑥) =
𝜙(𝑥)
Φ(𝑥)
, 𝜙(𝑥) and Φ(𝑥) are 
the pdf and cdf of standard normal distribution. 
Parameters Θ   can be estimated by iteratively running the estimation (E) and 
maximization (M) steps. In this study,  𝑍𝑐𝑢𝑡 is set for each gene as the logarithm of the 
minimal non-zero RPKM/FPKM/TPM value in the gene’s expression profile. The EM 
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algorithm is conducted for 𝐾 = 1, …, 9 to fit the expression profile of each gene and the 𝐾 
that gives the best fit is selected according to the Bayesian Information Criterion (BIC):  
𝐵𝐼𝐶 = −2 ln(Θ∗) + 3𝐾ln(𝑁) 
where 𝐾 is the number of TRS, 𝐾 is the number of conditions. 𝐾 that minimizes the BIC 
will be selected. 
Then the original gene expression values will be labeled to the most likely 
distribution under each condition. In detail, the probability that 𝑥  belongs to distribution 𝑖 
is formulated by:  
 𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, Θ
∗ ∝
𝛼𝑖
√2𝜋𝜎 
2
𝑒
−(𝑥𝑗−𝜇𝑖)
2
2𝜎𝑖
2
 
And 𝑥   is labeled by TRS 𝑖  if 𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, Θ
∗ =
max
𝑖=1,⋯,𝐾
(𝑝 𝑥 ∈ 𝑇𝑅𝑆 𝑖|𝐾, 𝛩
∗ ). In such a way, a row consisting of discrete values (1,2, 
, 𝐾) for each gene will be generated. 
2.2.2 KL Score 
A Kullback-Leibler divergence score (KL score) is introduced in QUBIC 2 to guide 
candidate-selection and biclustering optimization. The KL score of a bicluster is defined 
as: 
𝐾𝐿𝐵 =
1
𝑁
∑ ∑ 𝑅(𝑖, 𝑗) × 𝑙𝑜 
𝑅(𝑖, 𝑗)
𝑄(𝑖, 𝑗)
+
1
𝑀𝑖∈{ ,1}
𝑁
 =1
∑ ∑ 𝐶(𝑖, 𝑘) × 𝑙𝑜 
𝐶(𝑖, 𝑘)
𝑃(𝑖, 𝑘)
            
𝑖∈{ ,1}
𝑀
 =1
 
where 𝑁 and 𝑀 are the numbers of rows and columns of a submatrix B in MR, respectively. 
𝑅(𝑖, 𝑗) represents the proportion of element 𝑖 in row 𝑗 of B, 𝑄(𝑖, 𝑗) is the proportion of 𝑖 in 
the entire corresponding row, 𝐶(𝑖, 𝑘) is the proportion of 𝑖 in column 𝑘 of B, and 𝑃(𝑖, 𝑘) is 
the proportion of 𝑖 in the entire corresponding column.   
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Meanwhile, the KL score for a gene quantify the similarity between a candidate 
gene 𝑗 and a bicluster, which is defined as follows: 
𝐾𝐿 = ∑ 𝑅(𝑖, 𝑗) × 𝑙𝑜 
𝑅(𝑖, 𝑗)
𝑄(𝑖, 𝑗)𝑖∈{ ,1}
 
where 𝑅(𝑖, 𝑗) represent the proportion of 𝑖 under corresponding columns of the current 
bicluster. 
2.2.3 QUBIC2 Algorithm 
The QUBIC2 algorithm concludes as follows:  
Step 1 (Data discretization and qualitative representation): Given an expression 
matrix with log-transformed FPKM, RPKM or CPM value for genes, use LTMG model to 
fit data. Label the values to the most likely distribution to get a representing row for each 
gene. Split these rows into multiple rows to get the representative matrix MR (Figure 3A). 
Step 2 (Graph construction and seed selection): Construct a weighted graph for 
MR. Select a feasible seed from the seed list; Stop if the seed list is empty (Figure 3B). 
Step 3 (Build core bicluster): Build an initial bicluster by finding all the conditions 
under which the two genes of the seed have 1s in MR. Set these columns of the two genes 
as the current bicluster B = (I, J). Expand B by adding a new gene that has the most 1s in 
J, giving rise to a new bicluster B’ = (I’, J’), where I’ is I after adding the new gene and J’ 
is J by deleting those columns with 0s. If two genes have the same number of 1s in J, 
choose the one with larger KL similarity with B (Figure 3C). If KLB’ > KLB, set B to B’ 
and repeat Step 2, otherwise stop and denote B as Core. Go to Step 4. 
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Step 4 (Core expansion): Expand the Core horizontally and vertically under preset 
consistency level as follows: for each gene(row) i not in B, if the ratio between the number 
of 1s in row i under J and |J| is ≥c, mark it as an extended gene; for each condition (column) 
j not in B, if the ratio between the number of 1s in the column j among I and |I| is ≥c, mark 
it as an extended condition. (Figure 3D). Mark the intersected zone created by extended 
genes and conditions as a Dual searching pool (brown box in Figure 3D). Go to Step 5. 
Step 5 (Search Dual): Search Dual in the intersected expanded zone, using the 
same process in Step 3, output the bicluster with genes and conditions that come from Core 
and Dual (red box in Figure 3E). Delete current seed, go to step 1. 
2.2.4 Size-based P-value 
For well-annotated organisms, the P-value of an identified bicluster enriching 
with a specific regulatory pathway can be calculated based on a hypergeometric 
distribution. However, the known experimental annotation is currently limited, even for 
most well-studied model organisms (about half of the protein-coding genes of E. coli 
have solid experimental evidence for their function in KEGG and GO) [93]. This status 
still limits the capability of a systematic evaluation of all the identified biclusters. To fill 
this gap, we calculate an alternative size-based P-value as follows. For a binary 
representing matrix MR, containing 𝑚  rows and 𝑛  columns, suppose we obtain an 𝑚1-
by-𝑛1bicluster M1 with all the elements be 1s. The probability of 𝑛1 ≥ 𝑊 can be assessed 
by the following formula [94], giving rise to a P-value of the bicluster M1: 
𝑃(𝑛1 ≥ 𝑊) = lim
 →∞
𝑛 
−(𝛽+1) 𝑊−𝑠( 1, 0,𝛽) (log𝑏 𝑛 )
𝛽+1 
where 𝛼 =
𝑚0
 0
 , 𝛽 =
𝑚1
 1
 , 𝑏 =
1
𝑝
, 𝑝 = 𝑃 𝑀𝑖, = 1 = 1 − 𝑃 𝑀𝑖, = 0  for ∀𝑖, 𝑗 
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𝑠(𝑛1, 𝑛 , 𝛽) =
𝛽 + 1
𝛽
log𝑏 𝑛 −
𝛽 + 1
𝛽
log𝑏  
𝛽 + 1
𝛽
log𝑏 𝑛  + log𝑏 𝛼
+
(1 + 𝛽) log𝑏 𝑒 − 𝛽 log𝑏 𝛽
𝛽
 
 
2.3 Functional Gene Modules Detection from RNA-Seq Data   
2.3.1 Data Acquisition 
A total of four expression datasets were used in this section, that is, one synthetic 
RNA-Seq data (22,846 rows × 100 columns), one bulk RNA-Seq dataset from 
Escherichia coli (E. coli, 4,497 rows × 155 columns), a bulk RNA-Seq dataset from 
TCGA (3,084 rows × 8,555 columns), and a scRNA-Seq dataset from human embryos 
(3,798 genes × 90 cells). The synthetic dataset was simulated using our in-house 
simulation method (see Section 2.3.2). It contains 22,846 genes and 100 samples. A total 
of 10 co-regulated modules was embedded in this dataset, covering 2,240 up-regulated 
genes. The E. coli RNA-Seq data consists of 4,497 genes and 155 samples, which was 
integrated and aggregated by our group. In short, 155 fastq files were downloaded from 
ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ using the sratoolkit (v2.8.1, https://github.com/ncbi/sra-
tools/wiki/Downloads), and they are processed following quality check (FastQC), reads 
trimming (Btrim), reads mapping (HISAT2) and transcript counting (HTSeq). Then, raw 
read counts were RPKM normalized. The human RNA-Seq data contains 3,084 genes 
and 8,555 samples, which was obtained from [70]. The scRNA-Seq data was downloaded 
from [95] as an RPKM expression matrix with 20,214 gene and 90 cells, and then 3,798 
genes were kept for the analysis in this study by removing the genes without annotation.  
Multiple sets of known modules/biological pathways were provided or collected to 
support the enrichment analysis of the above four datasets. For synthetic data, the ten 
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groups of pre-defined up-regulated genes were used as co-regulated modules. For E. coli 
data, we used five kinds of biological pathways, which are complex regulons and regulons 
extracted from the RegulonDB database (version 9.4, accessed on 05/08/2017), KEGG 
pathways collected from the KEGG database (accessed on 08/08/2017), SEED subsystems 
from the SEED genomic database (accessed on 08/08/2017) [96], and EcoCyc pathways 
from the EcoCyc database (version 21.1, as of 08/08/2017) [97]. Complex regulons 
(ComTF) were defined as a group of genes that are regulated by the same transcription 
factor (TF) or the same set of TFs. In total, 457 complex regulons, 204 regulons, 123 KEGG 
pathways, 316 SEED subsystems, and 424 EcoCyc pathways were retrieved, respectively. 
For the human TCGA and scRNA-Seq data, we used three sets of modules provided by 
[70]. 
2.3.2 Simulation of Co-regulated Gene Expression Data 
We utilized a single cell RNA-Seq dataset of human melanoma [98] (with 22,846 
genes and 4,645 cells) to simulate bulk tissue RNA-Seq data with known co-regulated 
modules. Specifically, a single cell RNA-Seq pool consists counts data of 4,466 cells of 
six annotated cell types namely B-, T-, endothelial, fibroblast, macrophage, and cancer 
cells were constructed. The top 1,000 cell type specifically expressed genes of each cell 
type were identified by using Z score of the mean of each gene’s expression level in each 
cell type.  
For each round of simulation, the number of to be simulated bulk tissue samples 
and co-regulation modules is first defined. Then the genes of each co-regulation module 
denoted as 𝑋  will be specified by randomly selecting 𝑀  genes from the top 1,000 cell 
type specifically expressed genes of one cell type. A co-regulation strength matrix 𝑃 is then 
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simulated from a bimodal distribution over (0,1), with 𝑃[𝑖, 𝑘] denotes the proportion of 
cells with the transcriptional regulatory signal of co-regulation module 𝑘 in bulk sample 𝑖. 
A bulk tissue data is simulated by randomly drawing cells from the cell pool by following 
a multinomial distribution, with predefined parameters and the total number of cells. For 
co-regulation module 𝑘 in bulk sample 𝑖, genes 𝑋  in a proportion 𝑃[𝑖, 𝑘] of the selected 
cells of the cell type corresponds to 𝑘 are perturbed by an X-fold increase of the gene 
expression. Then the bulk data 𝑖 with simulated co-regulations are formed by summing the 
perturbed gene expression profile the selected cells and normalized to RPKM expression 
scale. The Pseudo code of the simulation approach is provided as follows: 
𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠 
𝑋 ≜ 𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑒𝑙𝑒 𝑡 𝑀   𝑒𝑛𝑒𝑠 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒  𝑒𝑙𝑙 𝑡𝑦𝑝𝑒 𝑠𝑝𝑒 𝑖𝑓𝑖 𝑎𝑙𝑙𝑦 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑  𝑒𝑛𝑒𝑠 𝑜𝑓 𝑜𝑛𝑒  𝑒𝑙𝑙 𝑡𝑦𝑝𝑒 
𝐹𝑜𝑟 𝑖 𝑖𝑛 1 𝑡𝑜 #𝐵𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎 
 𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠 
      𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑖𝑚𝑢𝑙𝑎𝑡𝑒 𝑃[𝑖, 𝑘] ≜ 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓  𝑒𝑙𝑙𝑠 𝑤𝑖𝑡ℎ 𝑎 𝑝𝑒𝑟𝑡𝑢𝑟𝑏𝑒𝑑 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛  
𝐹𝑜𝑟 𝑖 𝑖𝑛 1 𝑡𝑜 #𝐵𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎 
 𝑅𝑎𝑛𝑑𝑜𝑚𝑙𝑦 𝑠𝑒𝑙𝑒 𝑡 𝑁  𝑒𝑙𝑙𝑠 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒  𝑒𝑙𝑙 𝑝𝑜𝑜𝑙 𝑤𝑖𝑡ℎ 𝑎 𝑚𝑢𝑙𝑡𝑖𝑛𝑜𝑚𝑖𝑎𝑙 𝑑𝑖𝑠𝑡𝑟𝑖𝑏𝑢𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑟𝑒𝑝𝑙𝑎 𝑒𝑚𝑒𝑛𝑡  
                  𝐹𝑜𝑟 𝑘 𝑖𝑛 1 𝑡𝑜 # 𝑜 − 𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒𝑠 
                              𝐶ℎ𝑜𝑜𝑠𝑒 𝑃[𝑖, 𝑘] 𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑜𝑓  𝑒𝑙𝑙𝑠 𝑜𝑓 𝑡ℎ𝑒  𝑒𝑙𝑙 𝑡𝑦𝑝𝑒  𝑜𝑟𝑒𝑠𝑝𝑜𝑛𝑑𝑠 𝑡𝑜 𝑡ℎ𝑒  𝑜𝑟𝑒 𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑚𝑜𝑑𝑢𝑙𝑒 𝑘 
                                         𝑃𝑒𝑟𝑡𝑢𝑟𝑏 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑋  𝑖𝑛 𝑡ℎ𝑒  ℎ𝑜𝑠𝑒𝑛  𝑒𝑙𝑙𝑠 𝑏𝑦 𝑎 𝑋 − 𝑓𝑜𝑙𝑑 𝑖𝑛 𝑟𝑒𝑎𝑠𝑒  
                𝑆𝑖𝑚𝑢𝑙𝑎𝑡𝑒 𝑡ℎ𝑒 𝑖𝑡ℎ 𝑏𝑢𝑙𝑘 𝑡𝑖𝑠𝑠𝑢𝑒 𝑑𝑎𝑡𝑎 𝑏𝑦 𝑠𝑢𝑚 𝑜𝑓 𝑡ℎ𝑒 𝑝𝑒𝑟𝑡𝑢𝑟𝑏𝑒𝑑  𝑒𝑛𝑒 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑒𝑙𝑒 𝑡𝑒𝑑 𝑁  𝑒𝑙𝑙𝑠  
 
The rationales of this simulation approach include (1) gene expression level and 
noise in the bulk data are purely simulated by sum of real single-cell data, without using 
artificially assigned expressions scale and noise; (2) co-regulation genes are modeled as a 
specific fold increase of a number of cell-type-specific genes in a particular subset of the 
cells, which characterizes the heterogeneity of transcriptional regulation among cells in a 
tissue; (3) multiple co-regulation modules in specific to different cell types can be 
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simultaneously simulated. Hence, we believe the gene expression data simulated by this 
way can satisfactorily reflect genes co-regulated by a perturbed transcriptional regulation 
signal in real bulk tissue data. 
2.3.3 Evaluation of Functional Modules 
The capability of algorithms to recapitulate known functional modules are assessed 
using precision and recall. First, for each identified bicluster, we use the P-value of its most 
enriched functional class (biological pathway) as the P-value of the bicluster. Specifically, 
the probability of having 𝑥 genes of the same functional class in a bicluster of size 𝑛 from 
a genome with a total of 𝑁 genes can be computed using the following hypergeometric 
function[99]: 
P (𝑋 = 𝑥 𝑁, 𝑝, 𝑛) =
 𝑝𝑁
𝑥
  (1−𝑝)𝑁
 −𝑥
 
 𝑁
 
 
 
where 𝑝 is the percentage of that pathway among all pathways in the whole genome. The 
P-value of getting such enriched or even more enriched bicluster is calculated as: 
𝑃 − value = P(X ≥ x) = 1 − P(X < x) = 1 −∑
 𝑝𝑁
𝑖
  (1−𝑝)𝑁
 −𝑖
 
 𝑁
 
 
𝑥−1
𝑖= 
 
The bicluster is deemed enriched with that function if its P-value is smaller than a 
specific cutoff (e.g., 0.05). 
Given a group of biclusters identified by a tool under a parameter combination, the 
precision is defined as the fraction of observed biclusters significantly enriched with the 
one biological pathway/known modules (Benjamini-Hochberg adjusted p<0.05), 
𝑃𝑟𝑒 𝑖𝑠𝑖𝑜𝑛 =
# 𝑜𝑓 𝑠𝑖 𝑛𝑖𝑓𝑖 𝑎𝑛𝑡 𝑏𝑖 𝑙𝑢𝑠𝑡𝑒𝑟𝑠
# 𝑜𝑓 𝑏𝑖 𝑙𝑢𝑠𝑡𝑒𝑟𝑠 
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 For recall, we compute the fraction of known modules that were rediscovered by 
the algorithms, 
𝑅𝑒 𝑎𝑙𝑙 =
# 𝑜𝑓 𝑠𝑖 𝑛𝑖𝑓𝑖 𝑎𝑛𝑡 𝑚𝑜𝑑𝑢𝑙𝑒𝑠
# 𝑜𝑓 𝑚𝑜𝑑𝑢𝑙𝑒𝑠 
 
Finally, the harmonic mean of precision and recall were calculated to represent the 
performance of an algorithm on a given dataset and parameter setting, denoted as F score: 
𝐹 =
2
1
𝑃𝑟𝑒 𝑖𝑠𝑖𝑜𝑛 +
1
𝑅𝑒 𝑎𝑙𝑙
 
Note that the number of biclusters used to calculate precision and recall may 
affect the results. To make sure the evaluation is as fair as possible, for each dataset, we 
select the first 30 biclusters. 
2.3.4 Biclustering Parameters 
To assess the robustness, each tool is run multiple times by varying parameters that 
affect the size and number of biclusters. In general, parameters are adjusted around their 
default or recommended (if available) value. The parameters varied as well as details about 
the range and increment are listed in Table2. 
Table 2. Main parameter adjusted for each algorithm 
Algorithm Implementation Parameters Note 
Bimax R package ‘biclust’ minr ranges from 10~60(increment 5) 
minc ranges from 10~45 (increment 5) 
number set to 100 
Need discretized data as 
input. For each dataset, 
take the discretized data 
from QUBIC as input. 
No recommendation 
provided by the author 
or biclust manual. 
Default: minr=2, 
minc=2 
ISA R package ‘isa2’ set.seed ranges from 10~600, increment 10 ISA is stochastic, by 
setting different seeds 
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 may obtain different 
biclusters 
FABIA R package fabia‘ alpha ranges from 0~0.05, 
increament:0.01; 
spl ranges from 0~2, increment 0.5; 
spz ranges from 0~2, increment 0.5; 
cyc=100, p=100 
default: alpha=0.1, spl 
=0, spz=0.5, cyc=500, 
p=5 
Plaid R package ‘biclust’ both row.release and col.release range 
from 0.5~0.7, increment be 0.05 
max.layer 10~100 
for row.release and 
col.release, 0.5~0.7 is 
the recommended range 
QUBIC R package 
‘QUBIC’ 
f 0.1~1.0, increment 0.05 
c 0.8~1.0, increment 0.05 
k 3~23, increment 5 
default: f=1.0, c=0.95, 
k=ncol/20 
QUBIC2 C++   f 0.25~1.0, increment 0.05 
k 5~23, increment 5 
 
 
2.3.5 Results 
Compared with five biclustering algorithms (Bimax [30], ISA [100], FABIA [37], 
Plaid [16], and QUBIC [31]), the performance of QUBIC2 in identifying FGMs was 
systematically evaluated using four gene expression datasets. For the identified biclusters 
from a specific tool, precision showcases the fraction of biclusters whose genes are 
significantly enriched with specific biological pathways (i.e., relevance), and recall 
reflects the fraction of captured known modules/pathways among all known modules in a 
functional annotation database, e.g., KEGG [101] and RegulonDB [102] (i.e., diversity). 
The harmonic mean value of precision and recall, referred to as the F score, was used as 
the integrated criteria in performance evaluation. 
Evaluation studies usually used default parameters of the to-be-analyzed tools, 
which were optimized for specific benchmark datasets. However, when applied to 
datasets coming from a different organism (e.g., E. coli vs. human), or be acquired by 
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other technologies (e.g., microarray vs. RNA-Seq), the default parameters often fail to 
achieve satisfying performance and need further optimization/adjustment. To minimize 
the biases in performance comparison among multiple tools, for each of the four datasets, 
we run the six tools under more than 50 parameter combinations by adjusting their 
critical parameters around default/recommended values. Then the F score of identified 
biclusters under each parameter combination was calculated. In this way, we can test a 
tool’s robustness and infer how sensitive of its performance is to parameter adjustment, 
besides the basic performance comparison among different tools. 
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Figure 4. Overall performance comparison between QUBIC2 and five popular biclustering methods based on the agreement between identified 
biclusters and known modules. A. Distribution of F scores on each of the four datasets under multiple runs (n>40). Black line in the box denote 
median value, whiskers denote 10% and 90% percentiles, while the box denotes 25% and 75% percentiles; B. relative performance of six 
algorithms in terms of F score under default parameters, variance of F scores under multiple sets of parameters, median value for the precision and 
median value for the recall, respectively (normalized over six algorithms). Note that the variance of F scores depends on the increment of 
parameters, and therefore only indicative. 
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As showcased in Figure 4, QUBIC2 achieved the highest median F scores and the 
highest F scores with the default parameter on all the four datasets, and its F scores were 
significantly higher than the second-best algorithms in all the comparison circumstances 
(Wilcoxon test P-value <0.01). QUBIC2 performed well in both precision and recall, 
indicating that the identified FGMs are relevant and diverse; and it had relatively small 
variance, while the performance of some algorithms on specific dataset was susceptible to 
parameter change (e.g., FABIA on E. coli). Regarding median F scores, QUBIC was the 
second-best algorithm on simulated data, E. coli RNA-Seq data, and human scRNA-Seq 
data, while FABIA was the second-best one for TCGA data. As regards the default settings, 
QUBIC ranked as the top ones on simulated data and E. coli data, and ISA and Plaid had 
relative higher rank on TCGA data. ISA was generally very stable, and its variances were 
the smallest on three datasets. As for Bimax, although its recall was relatively low, it was 
characterized with high precision on the four datasets. It is noteworthy that QUBIC2 is the 
only program, among all the six biclustering algorithms, which did not encounter a 
dramatic performance drop on scRNA-Seq data compared to RNA-Seq data, suggesting 
the unique applicative power of QUBIC2 on FGMs detection from scRNA-Seq data.  
Furthermore, the performance of all the biclustering algorithms on E. coli data was 
better than on human data, with the possible reason that E. coli data has more completed 
functional annotation and affects the evaluation of module significance. Therefore, for less 
annotated organisms, we need a statistical evaluation framework for all the identified 
biclusters. 
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2.4 A Statistical Evaluation Framework for Identified Biclusters 
The significances of gene modules from the identified biclusters were usually 
evaluated by pathway enrichment analysis. However, many organisms (including human) 
have limited functional annotations supported by experimentally verifications, which 
makes a systematic evaluation of all identified biclusters non-trivial. To fill this gap, a 
statistical method was proposed in QUBIC2, which can calculate a P-value for a bicluster 
purely based on their size. To evaluate the validity of the proposed method, a Spearman 
correlation test was conducted. 
2.4.1 Methods 
QUBIC2 was run on the E. coli RNA-Seq data under 63 parameter settings. For 
each setting, around 100 biclusters were identified. Five sets of regulatory or metabolic 
pathways were extracted from four databases of  E. coli (RegulonDB, KEGG, SEED [96] 
and EcoCyc [97]) to support this association study.  In specific, for each set of ~100 
biclusters obtained under the same settings, six groups of P-values for all these biclusters 
were calculated, with five groups of P-values derived via pathway enrichment analysis 
(named knowledge-based P-values) and one group of P-values computed using our size-
based method. Spearman correlation test was conducted to investigate the rank-order 
correlation among the six groups of P-values. Five correlation coefficients (ρ), which 
demonstrated the extent of correlation between size-based P-values and five biological 
knowledge-based P-values, as well as five corresponding p-values, were recorded from the 
test. Note that the p-value of correlation test denotes the probability of observing such a 
correlation or even stronger correlation, under the null hypothesis that no correlation exists. 
For simplicity, the correlation coefficient between the size-based P-value and biological 
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knowledge-based P-value was prefixed with the name of a pathway, e.g., TF_ρ  and 
KEGG_ ρ . In the end, a total of 5 × 63 ρ (63 parameter settings, each with five ρs) and 
the same number of p-values were obtained. 
 
Figure 5.A. The distribution of correlation coefficients(ρ) between P-value obtained from 
enrichment analysis and size-based P-value. We run QUBIC2 under 63 different parameter 
settings, and ρ was calculated under each run; B. Scatter plot of ρ and p-value. The y-axis denotes 
ρ, the correlation coefficient for the Spearman association test, the x-axis denotes the p-value of 
the association test. Note that to distinguish, italic lowercase p was used to denote the p-value of 
the Spearman correlation test, while italic uppercase P was used to denote the significance of 
biclusters. 
 
2.4.2 Results 
Interestingly, we found that there is a strong association between the knowledge-
based P-value and the corresponding size-based P-values. The average Spearman 
correlation coefficients (ρ) were higher than 0.40 (ComTF_ρ =0.48, TF_ρ=0.56, KEGG_ρ 
=0.42, SEED_ρ=0.43 and ECO_ρ =0.42), and the average p-values for the correlation test 
were smaller than 0.01. As showcased in Figure 5A, all the ρs in the five groups are 
positive. Besides, ρs related with regulatory pathways (i.e., TF_ ρ and ComTF_ ρ) were 
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generally larger than ρ s those related to metabolic pathways (i.e., KEGG_  ρ  and 
SEED_ ρ). This indicated that the size-based P-value seemed to be more suitable for the 
evaluation of biclusters’ regulatory significance. Furthermore, all the corresponding p-
values were less than 0.05 (Figure 5B), suggesting that the correlations between 
knowledge-based P-values and size-based P-values were statistically significant at the 0.05 
level. Also, the parameter f which controls the level of overlaps between biclusters had a 
negative association with ρ (Figure 6), suggesting that the size-based P-values would have 
a stronger association with knowledge-based P-values when the overlaps between 
biclusters are relatively low. 
Figure 6. The relationship between biclustering parameter f and correlation coefficient that 
indicates the association between biological knowledge-based P-value and size-based P-value. 
The blue line in each plot corresponds to the Loess smooth line. 
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2.5 Cell Type Classification Based on scRNA-Seq Data 
The above sections demonstrated the outstanding performance of QUBIC2 on 
FGMs identification and its unique feature of statistical evaluation for all the identified 
biclusters. In this section, we showed the predictive power of biclustering methods on cell 
types identification from scRNA-Seq data.  
2.5.1 Cell Type Classification Pipeline  
By using biclustering, we can group genes and cells simultaneously. However, 
since biclustering aims to find sets of genes that are co-expressed across a subset of 
conditions, it is possible that genes may co-expressed across multiple cell types. 
Therefore, one bicluster may consist of cells from different types, and cells from the same 
types may appear in different biclusters. In a word, it is not guaranteed that one bicluster 
corresponds to one cell type. However, it is assumed that two cells from a bicluster are 
more likely to be of the same subtypes than the two cells that are randomly selected. It is 
believed that biclusters can capture this feature to some extent. If there are multiple 
biclusters and when we condense them together, we can distinguish sets of cells 
belonging to the same type from sets of cells that are grouped by chance. 
Based on the above idea, we developed a pipeline to obtain cell type classification 
based on biclustering results (Figure 7A). First, a biclustering tool was applied to the 
expression data (rows represent genes and columns represent cells) to identify a set of 
biclusters. Then a weighted graph 𝐺 = (𝐶, 𝐸)  was constructed to model the relationship 
between cell pairs among biclusters. A node  𝑖 in 𝐺 represented a cell, and 𝑒𝑖,  represented 
the edge connecting  𝑖 and   , where 𝑖 ≠ 𝑗. We assigned weight 𝑤𝑖,  to 𝑒𝑖,  to represent the 
number of biclusters that contain both  𝑖 and   . Intuitively, a higher 𝑤𝑖,  value indicates 
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that  
𝑖  
and  
 
 are simultaneously involved in more biclusters, hence, are more likely to be 
the same cell type than cell pairs with lower weight. A symmetrical cell-cell matrix with 
diagonal as 0 was then constructed to record 𝑤𝑖,  and Markov Cluster Algorithm (MCL) 
was performed to cluster cells into cell types and produce cell labels. In specific, the MCL 
clustering was run 100 times by varying inflation factor from 1 to 100, resulting 100 cell 
labels. A binary similarity matrix was constructed for each cell label: if two cells belong to 
the same cluster, their similarity is 1; otherwise, the similarity is 0. Then a consensus matrix 
was built by averaging all similarity matrices. The resulting consensus matrix was clustered 
using hierarchical clustering with complete agglomeration, and the clusters were inferred 
at the k level of the hierarchy, where k is the chosen based on the average silhouette score 
of that 100 MCL clustering results. 
2.5.2 Data, Biclustering Parameters and Evaluation Criteria 
One golden-standard scRNA-Seq data [95] was used. It consists of 20,214 genes 
and 90 cells, where the cells were assigned into seven subgroups with the true cell 
subtypes information provided in [95]. 
For each of the six biclustering methods, we applied the classification pipeline to 
the above dataset. Each tool was run under multiple parameter settings. The details about 
the range of parameters are given in Table3. 
Table 3. Parameter ranges for each biclustering algorithm used in the cell type 
classification section 
Algorithm Parameters Note 
Bimax minr 10~200, increment 10 
minc 10~30, increment 10 
number=2000 
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ISA set.seed ranges from 10~600, increment 10  
FABIA alpha 0.01~0.5, increment 0.01 
spl 0~2, increment 0.05; 
spz 0~2, increment 0.05 
p=50 
tried to set p=100, 1000, 2000, but 
got error message ‘too many 
biclusters’ and aborted 
Plaid row.release 0.5~0.7 
col.release 0.5~0.7 
max.layer 10~100 
 
QUBIC f 0.5~1.0, increment 0.05; 
c 0.8~0.95, increment 0.05; 
k =13;  
o =2000 
default o=100 
QUBIC2 f 0.6~1.0, increment 0.05; 
c 0.8~0.95, increment 0.05; 
k = 4,13 
o = 2000 
 
 
The Adjusted Rand Index (ARI) was adopted as the evaluation criteria to access the 
agreement between predicted cell types and these ‘ground truth' [103]. Two more external 
validation criteria, namely Jaccard Index (JI) and Fowlkes Mallows Index (FMI), were also 
used here aiming to provide a comprehensive evaluation. 
Specifically, external validation measures the extent to which cluster labels match 
externally supplied class labels. Generally, they are based on counting the pairs of points 
on which two classifiers agree/disagree. Denote two partitions of the same data set as R 
and Q. The reference partition, R, encode the class labels, i.e., it partitions the data into k 
known classes.  Partition Q, in turn, partitions the data into v categories, which is the one 
to be evaluated. 
Adjusted Rand Index (ARI) is defined as 
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𝐴𝑅𝐼 =
𝑎 −
(𝑎 +  )(𝑎 + 𝑏)
𝑑
(𝑎 +  ) + (𝑎 + 𝑏)
2 −
(𝑎 +  )(𝑎 + 𝑏)
𝑑
 
a: Number of pairs of data objects belonging to the same class in R and the same 
cluster in Q. 
b: Number of pairs of data objects belonging to the same class in R and different 
clusters in Q. 
c: Number of pairs of data objects belonging to different classes in R and the same 
cluster in Q. 
d: Number of pairs of data objects belonging to different classes in R and different 
clusters in Q. 
Terms a and d are measures of consistent classifications (agreements), whereas 
terms b and c are measures of inconsistent classifications (disagreements). 
Jaccard Index is defined as: 
𝐽𝐼 =
𝑎
𝑎 + 𝑏 +  
 
The Jaccard Index can be seen as a proportion of good pairs with respect to the sum 
of non-neutral (good plus bad) pairs. 
Folkes-Mallow's index is defined as 
𝐹𝐼 =
𝑎
√(𝑎 + 𝑏)(𝑎 +  )
 
Fowlkes–Mallow's index can be seen as a non-linear modification of the Jaccard 
coefficient that also keeps normality. 
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2.5.3 Results  
The performance of QUBIC2 was compared with five biclustering methods 
(QUBIC, FABIA, ISA, Plaid and Bimax) and three cell type prediction methods 
(SC3[95], SINCERA[104], and SNN-Cliq[105]). It is found that the average ARI score, 
as a representative, of QUBIC2 was 37%, 220%, 632%, 151%, and 185% higher than the 
other five biclustering methods, respectively; and was 30%, 67% and 62% higher than 
the three cell type prediction methods, respectively. QUBIC2 and QUBIC were the top 
two biclustering tools, respectively, in terms of median values on the three criteria. Both 
surpassed the performance of SC3 (median value from 100 runs, denoted by the red dash 
line in each panel of Figure 7B). Besides, ISA always demonstrated the smallest variance 
across the three validation criteria. The FMI values of each tool were more stable than the 
other two values. Figure 7C showcased one cell type classification result obtained by 
QUBIC2. The result was in good agreement with the reference cell labels and QUBIC2 
correctly grouped the three major cell types (8_cell_embryo, Morulae, and 
late_blastoCyst). 
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Figure 7. A. Computational pipeline for cell type classification. This pipeline consists of three 
steps: biclustering, generation of weighted cell-cell matrix and clustering using MCL; B. 
Benchmark of QUBIC2 against five popular biclustering algorithms. Each panel shows the 
similarity between the inferred labels and the reference labels quantified by ARI, FW and JI, 
respectively. Each algorithm was applied >40 times to the same dataset. The three indices were 
calculated for each run of the respective methods (black dots). Bars represent the median of the 
distribution of black dots. The red dash lines correspond to the benchmark performance of SC3 
(ARI: 0.6549, FMI: 0.7243, JI: 0.5671); C. Sankey diagram comparing the 7 clusters obtained 
with SC3 (right layer) and 6 clusters obtained with QUBIC2 (left layer). The middle layer 
corresponds to the seven reference clusters. The widths of the lines linking nodes from two layers 
correspond to the number of cells they have in common. 
 
2.6 Application of QUBIC2 on Temporal and Spatial scRNA-Seq Data 
When spatial and temporal information is available, scRNA-Seq can reveal more 
biological insights beyond cell types. In this section, QUBIC2 was applied on two 
temporal (and) and two spatial scRNA-Seq datasets, respectively, to explore the temporal 
and spatial organization of cells. 
2.6.1 Data 
The time series lung scRNA-Seq dataset (GSE52583) with 152 cells and 15,174 
genes from was downloaded from http://www.cs.cmu.edu/~jund/scdiff/download/data/. 
The cells were collected at three time points: E14, E16, and E18. Another time series 
scRNA-Seq data with 527 cells and 13991 genes (GSE48968) was downloaded from the 
GEO database, in which the RPKM values are available.  
The Mouse olfactory bulb spatial transcriptomic data was downloaded from 
[106], which contains 280 cells and 15,981 genes. Ståhl et al. [106] classified the cells 
into five clusters that correspond to well-defined morphological layers. The cells use 
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coordinates as IDs, and the cell layers information was manually extracted using the ST 
viewer (https://github.com/SpatialTranscriptomicsResearch/st_viewer), based on the 
coordinate information. The raw reads of mouse spatial scRNA-Seq data GSE60402 were 
retrieved from the SRA database [107], and the RPKM values for it were calculated using 
software packages TopHat [108] and Cufflink [109]. GSE60402 was split into three 
subsets according to sample information. The detailed information of the selected and 
divided datasets is listed in Table 4. 
Table 4. Summary of GSE60402 
GEO Accession ID Data ID Description #Cells #Genes 
GSE60402 GSE60402-Mutant From Gfra1 mutant sample 94 11094 
GSE60402 GSE60402-Wildtype1 From wild type mouse 1 124 10037 
GSE60402 GSE60402-Wildtype2 From wild type mouse 2 94 10714 
 
2.6.2 Results 
QUBIC2 identified five biclusters from GSE52583. Three of the five biclusters 
contain time-specific cells. In particular, bicluster BC002 consists of cells exclusively 
from E14; bicluster BC003 includes cells that only from E16; and bicluster BC004 has 
cells coming from E18 (Figure 8A). Functional enrichment analyses of the component 
genes from these three biclusters were carried out based on DAVID [110], and the results 
showed that genes in BC002 mainly related to cell cycle, cell division, and mitosis; 
BC003 genes were enriched with ribosome, translation, and structural constituent of 
ribosome; and spliceosome-related genes were grouped in BC004. 
In addition to identifying biclusters corresponding to specific time point, QUBIC2 
can also be used to find biclusters with time-dependent patterns. Here QUBIC2 was used 
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to analyze a scRNA-Seq data with mouse dendritic cells (DCs) collected at 1h, 2h, 4h and 
6h after treatment with pathogenic agent lipopolysaccharide (LPS) and untreated controls 
(GSE48968) [111]. In total, 51 biclusters were identified in the datasets treated with LPS. 
For each bicluster, the Fisher exact test was conducted on its constituting samples to assess 
if significant over-representation by any time points could be found within the bicluster. 
For those biclusters showing significant association with the time-course, a pathway 
enrichment analysis was conducted to infer the biological characteristics of the bicluster. 
In detail, pathway enrichment analysis is undertaken and the statistical significance of each 
enriched pathway is assessed by using a hypergeometric test (statistical significance cutoff 
= 0.005) against 4,725 curated gene sets in the MsigDB database, which includes 1,330 
canonical KEGG, Biocarta and Reactome pathways, and 3,395 gene sets representing 
expression signatures derived from experiments with genetic and chemical perturbations, 
together with 6,215 Mouse GO terms each containing at least 5 genes [112, 113]. In the 
end, 30 biclusters that are significantly over-represented by one or several consecutive time 
points were identified in the LPS dataset (α=0.005, P<1e-22), and six of them showed clear 
time dependence (Figure 8B). Specifically, bicluster BC013 consists of untreated samples 
and samples collected at 1h, which represents the earliest response to LPS and enriches 
multiple immune response pathways. Bicluster BC005 consists mainly of untreated 
samples and samples collected at 1h and 2h, which also is enriched with immune response 
pathways but with more responses to a virus, T cell chemotaxis and so on. BC009 and 
BC001 are enriched by samples collected at 1h and 2h, covering a wider range of stress-
response pathways, suggesting that the activation of stress response pathways and altered 
metabolisms as secondary responses after the early immune response. BC025 and BC002 
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consist of samples collected at 4h and 6h, and their genes enrich pathways associated with 
alterations in cell morphogenesis, migration, cell-cell junction and so on. Overall these 
observations suggest that our analysis can identify all the major responses to the LPS 
treatment in a time-dependent manner.  
Figure 8. A. Visualization of three biclusters (BC002, BC003, and BC004) selected based on the 
specificity to time point; B. Time-dependent distribution of cells in six selected biclusters 
identified in the LPS data. In each histogram, the five bars from left to right show the proportion 
of the untreated samples and samples collected at 1h, 2h, 4h and 6h after the LPS treatment. 
 
Then QUBIC2 was applied to a mouse spatial scRNA-Seq dataset with 280 cells. 
The cells were classified into five clusters that correspond to five distinct morphological 
layers in [106] (Figure 9A). Five biclusters were predicted. Among them, the bicluster 
BC000 consists of cells mainly from the granular layer; the bicluster BC001 contains cells 
from the mitral layer and glomerular layer; the bicluster BC002 includes cells mostly from 
the olfactory nerve layer (Figure 9B). Functional annotation showed that BC000 mainly 
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enriches plasma membrane, cell membrane, and cell projection; BC001 enriches synapse, 
neuron projection, and cell projection; and BC002 enriches cell projection.  
Figure 9. A. The coordinates of cells correspond to five morphological layers (1. Granular cell 
layer; 2. Mitral cell layer; 3. Outer plexiform layer; 4. Glomerular layer; 5. Olfactory nerve 
layer); B. The coordinates of cells from three selected biclusters; C. The spatial coordinates of 
samples in the four biclusters identified in wild-type 1 mouse; Colors red, green, cyan and dark 
blue represent samples in four different biclusters; D. In addition to the coordinates of bicluster 
samples, the yellow cubes represent significant outlier samples; E. The same information as in C 
except the samples are from wild-type 2 mouse; F. The same information as in D except the 
samples are from wild-type 2 mouse. 
 
Finally, another spatial scRNA-Seq dataset (GSE60402) with samples dissected 
from three mouse medial ganglionic eminence tissues and known spatial coordinates was 
analyzed. QUBIC2 was applied, and 37, 40, and 120 biclusters were identified in the 
mutant, wild-type 1, and wild-type 2 datasets, respectively. Further investigation on the 
spatial distribution of cells in each bicluster showed that all the four spatial biclusters 
with distinct expression patterns by cell cycle, cell morphogenesis, and neuron 
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development genes, as reported in the original study [114], were identified by QUBIC2. 
It is noteworthy that the outliers with highly expressed stem cell markers tend to be 
located at the intermediate region between two adjacent (or overlapping) biclusters in the 
three datasets as shown in Figure 9D and 9F. Our interpretation is that these location-
dependent expression patterns may be caused by parallel and independent differentiations 
from common stem cells. 
2.7 Summary 
The combination of biclustering and large-scale gene expression data holds a 
promising potential in elucidating the functional pathways/networks encoded in a 
genome. However existing biclustering tools fail to generate satisfactory results from 
high-resolution RNA-Sequencing (RNA-Seq) data due to the lack of full consideration of 
(i) intrinsic characteristics of RNA-Seq data, e.g., the massive zeros in both bulk and 
scRNA-Seq data, and (ii) the underlying transcriptional regulation signals of gene 
expression. Here we presented a novel biclustering algorithm, QUBIC2, for the analysis 
of large-scale bulk RNA-Seq and scRNA-Seq data. QUBIC2 (i) used a truncated model 
to handle the unquantifiable errors caused by zeros, (ii) adopted an information-
divergency objective function to optimize to-be-identified biclusters, (iii) utilized a Core-
Dual strategy to recruit novel genes and optimize parameters in identifying a bicluster, 
and (iv) developed a size-based P-value calculation method to evaluate the statistical 
significances of all the identified biclusters. 
Our method validation on comprehensive data sets showed that QUBIC2 had 
significant advantages in the functional module detection area, outperforming five 
widely-used biclustering methods. The proposed P-value calculation method based on 
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bicluster size did make sense, which may facilitate the evaluation of all the identified 
biclusters, especially from less-annotated organisms. The cell type classification pipeline, 
based on QUBIC2, worked well and outperformed the state-of-the-art performance of 
SC3. By utilizing time-dependent data, QUBIC2 discovered biclusters specific to time 
point and identified a cascade of immune responses to the external pathogenic treatment. 
From the spatial transcriptomic data, QUBIC2 discovered that spatially adjacent single 
cells might have high co-expression patterns, and particularly, two distinct spatially 
clustered cells may be derived initially from the same stem cell. We believe that QUBIC2 
can serve biologists as a useful tool to extract novel biological insights from large-scale 
RNA-Seq data. 
Although the advantages mentioned above, to fully excavate the potential of 
scRNA-Seq data, there are several shortcomings needed to be overcome. First, as 
sequencing costs decrease, larger scRNA-Seq datasets will become increasingly common; 
thus, the scalability to large dataset and efficiency of tools will become more and more 
critical. Currently, the discretization and Dual searching functions of QUBIC2 are time-
consuming on large-scale datasets. Based on our test, it takes 17 minutes to discretize a 
dataset with 4,297 rows and 466 columns (a desktop with 48.0GB memory, Intel Core i7-
6700, and 3.40GHz). Given a dataset with 22,846 genes and 100 conditions, the running 
time while using Dual strategy are generally 2 minutes longer than that without Dual. The 
OpenMP method will be implemented in the EM steps for discretization, and more efficient 
heuristics algorithm will be designed to optimize the dual searching of biclustering. 
Another challenge involves the interpretation of time-series and spatial data. For 
example, in the GSE52583 data, QUBIC2 could only separate cells collected at different 
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time points, yet the further differentiation stage information was not captured. For the 
mouse olfactory bulb data, QUBIC2 did not separate cells from adjacent layers. To deal 
with this drawback, we need to combine biclustering with other statistical methods 
specifically designed for time series and spatial gene expression data. 
It is noteworthy that many other kinds of methods can be used for gene expression 
data analysis. Forty-two module detection tools covering five main approaches were 
reviewed in [70], and the authors concluded that decomposition methods outperformed 
all other strategies, including biclustering methods. Meanwhile, they also observed that 
QUBIC and FABIA had higher performance on human and synthetic data. We compared 
two top-rated decomposition methods and two top clustering methods with QUBIC2 and 
QUBIC on a human scRNA-Seq data; the results showed that QUBIC2 surpassed both 
decomposition and clustering methods (Figure 10). In the future, we will carry out a 
more comprehensive comparison between QUBIC2 and other decomposition and 
network-based methods, aiming to give a systematical evaluation of the power of 
computational techniques on scRNA-Seq data. 
Figure 10. Performance of QUBIC2, QUBIC, two decomposition methods and two clustering 
methods in term of F score on a human scRNA-Seq data. 
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CHAPTER 3: QUBICR- A Biconductor Package for Qualitative Biclustering Analysis of 
Gene Co-expression Data 
Biclustering is a widely accepted approach for gene expression data mining. 
Several biclustering algorithms have been published in the past two decades, and QUBIC 
has been reviewed as one of the best programs by several review studies. To enable the 
biclustering users lacking comprehensive computational background, a web server of 
QUBIC was developed in 2012 [23]. Since gene expression datasets keep increasing in 
scale, we developed this user requested R package of QUBIC (QUBIC-R for short), to 
provide an efficient optimized implementation and to eliminate large-scale data submission 
to a webserver.  
The unique features of QUBIC-R include: (i) biclustering is integrated with 
analyses functions, i.e., data discretization, query-based biclustering, bicluster expanding, 
biclusters comparison, heatmap visualization and co-expression network elucidation 
(Figure 11A); (ii) the QUBIC source code is optimized and converted from GNU C to 
C++, thus has better memory control and is more efficient than the original QUBIC (an 
average 82.4% saving of running time); (iii) on five large-scale datasets, QUBIC-R 
consistently performs the best among four popular tools according to the running time 
(Figure 11B). In the following part, I will present the main features of QUBICR. 
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Figure 11. A. Comparison of QUBIC-R and 6 R packages in biclust. Yellow color indicates that a 
package provides the function or is recommended in a specific biclustering application and gray 
color represents the opposite; B. Comparison of running time among four recommended 
programs, annotated with asterisks in Figure 11A; C. Heatmap visualization of two biclusters 
identified in E. coli data; D. Co-expression networks of Figure 11C biclusters. Green nodes 
represent bicluster #3 and red nodes represent bicluster #7. The larger the size of a node, the 
higher its degree of presence; and the thicker an edge the heavier its co-expression value is. 
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3.1 Implementation 
QUBIC-R package [115] is developed for the R statistical computing environment, 
and is freely available at http://bioconductor.org/packages/release/bioc/html/QUBIC.html. 
It depends on the biclust package developed by Kaiser et al. [48] to be compatible with the 
biclust output. Its output format can also be used by network analysis software, such as 
Cytoscape [116]. 
    The original QUBIC program, written in GNU C with POSIX library, is limited 
in its portability. A memory leak may occur if the primary functions are called more than 
once. This problem was addressed by refactoring the C source code and transforming it 
into C++. Specifically, to avoid memory leak, we changed the majority of data structures 
and replaced C pointers by STL containers. We also optimized core function structures to 
facilitate future package updates and developments. The program efficiency has been 
significantly increased with the same predicting results (Figure 11A).  An input data as 
large as 30,000×30,000 can be finished within half an hour (detailed limits test is in Figure 
12). All the computational experiments were conducted on a computer with Windows 7 
x64, Memory 48G, Intel Core i7-6700 3.4G. 
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Figure 12. Data limit test of QUBICR on simulated datasets. In this test, n-by-n matrixes were 
generated with increasing number of n (1,000, 2,000, 3,000, 4,000, 5,000, 6,000, 7,000, 8,000, 
9,000, 10,000, 15,000, 20,000, 25,000, 30,000). Each matrix was planted with several non-
overlapped 10-by-10, 10-by-20, or 20-by-10 biclusters (corresponding to the 1:1,1:2 or 2:1 row-
column-ratio, respectively). Default parameters of QUBICR were applied (c=0.95, r=1, f=1, 
q=0.06, o=100, k=max(ncol(x)%/%20,2)), and the running time in y-axis is in its log2 scale.  
 
3.2 Functions 
(i) qudiscretize is useful to obtain discrete gene expression matrix.  This matrix 
can be used in other biclustering program, where -1 represents lowly express, 0 
represents normally express, and 1 represents highly express. For example: 
library(QUBIC) 
matrix1 <- ecoli[1:3, 1:4] 
matrix1 
##       dinI_U_N0025 dinP_U_N0025 lexA_U_N0025 lon_U_N0025 
## b4634     9.077693     9.225537     9.138900    9.114353 
## b3241     7.122300     7.195453     7.051193    7.124200 
## b3240     7.184417     7.336610     7.283377    7.188263 
 
matrix2 <- qudiscretize(matrix1) 
matrix2 
##       dinI_U_N0025 dinP_U_N0025 lexA_U_N0025 lon_U_N0025 
## b4634           -1            1            0           0 
## b3241            0            1           -1           0 
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## b3240           -1            1            0           0 
 
(ii) BCQU and (iii) BCQUD are used to perform biclustering for continuous and 
discretized gene expression data, respectively: 
# QUBic-R on continuous data 
res <- biclust(ecoli, method = BCQU(), f = 0.25,verbose=F) 
res 
##  
## Number of Clusters found:  19  
##  
## Cluster sizes: 
##                   BC 1 BC 2 BC 3 BC 4 BC 5  
## Number of Rows:    437  121   51  108  103     
## Number of Columns:  29   45   94   44   38   
 
# QUBIC-R on discrete data 
res1 <- biclust(x = qudiscretize(ecoli), method = BCQUD(), f = 0.25, ve
rbose=F) 
res1 
# QUBIC algorithm can be called independently via qubiclust and qubiclu
st_d for both continuous and discrete data, respectively: 
 
res2 <- qubiclust(x = ecoli, f = 0.25, verbose=F) 
res2 
res3 <- qubiclust_d(x = qudiscretize(ecoli), f = 0.25) 
res3 
# note that res, res1, res2 and res3 are the same 
 
(iv) Using the parameter weight, a user can conduct a query-based biclustering, 
with additional biological information.  
Specifically, a user can input additional biological information and utilize that 
information to guide the biclustering progress in QUBICR, using the newly-added 
parameter weight. This kind of function is so-called query-based biclustering and has been 
widely applied in bioinformatics [24, 117] . The format of this input file should be 
supported by igraph, e.g., a file with three columns with column #1 and #2 representing 
the gene names and column #3 being the score of the two genes. QUBICR will (step 1) 
rank all the gene pairs in this additional input file, according to the corresponding biological 
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information (e.g., protein-protein interaction information or co-regulation relationship), in 
an increasing order; (step 2) rank all the gene pair in original gene expression data, 
according to their co-expression similarity trained from the QUBIC algorithm, in an 
increasing order; and (step 3) add the two ranks together for each gene pair. Then the 
summed ranks will be used as a new weight for each gene pair for all the following 
biclustering procedures. It is noteworthy that if a gene pair appears in this additional input 
file but not in original gene expression file (or in the opposite situation), its rank in step 1 
will be assigned as 0. 
In this example, the instance file “511145.protein.links.v10.txt” was downloaded 
from string 
(http://stringdb.org/download/protein.links.v10/511145.protein.links.v10.txt.gz). Note 
that after using the weight parameter, the output biclusters changed. 
# Conduct a query-based biclustering by adding the weight parameter 
library(QUBIC) 
library(QUBICdata) 
data("ecoli") 
library(igraph) 
file = "511145.protein.links.v10.txt "; 
graph = read.graph(file, format = "ncol") 
get.edgelist(graph, names = TRUE) 
E(graph)$weight 
weight <- get.adjacency(graph, attr = "weight") 
res0 <- biclust(ecoli, method = BCQU(),verbose = F) 
res0 
 
res4<- biclust(ecoli, method = BCQU(), weight = weight, verbose = F) 
res4 
(v) Using the seedbicluster parameter, a user can expand existing biclusters by 
recruiting more genes according to specified consistency level. The existing biclusters can 
be any biclustering results obtained from QUBICR or from any other algorithms in the 
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biclust package. This function has been successfully applied in [118] and a flowchart of 
this function can be found in Figure 1 of [118].  
In the following example, we expand previously obtained biclusters by QUBICR 
(res). Note that number of genes in some biclusters increase after expanding (e.g., 437 
genes in BC1 from res vs 593 genes in BC1 from res5). 
res5 <- biclust(x = ecoli, method = BCQU(), seedbicluster = res, f = 0.
25,verbose = F) 
res5 
##  
## Number of Clusters found:  19  
##  
## Cluster sizes: 
##                  BC 1 BC 2 BC 3 BC 4 BC 5  
## Number of Rows:    593  151   51  110  117  
## Number of Columns:  29   45   94   44   38   
 
 
(vi) Using the parameter showinfo, the biclustering results from different 
algorithms or from a same algorithm with different combinations of parameter can be 
compared. Specifically, we can compare the number of detected biclusters, the row number 
and column number of the first bicluster, the area of the first bicluser, the overlap of first 
two biclusters , and so on. 
test <-ecoli [1:50,] 
res6 <-biclust(test, method = BCQU(), verbose = F) 
res7 <- biclust (test, method = BCCC()) 
res8 <- biclust(test, method = BCBimax()) 
showinfo (test, c(res6, res7, res8)   
  (vii) The function quheatmap can visualize the identified biclusters using heatmap 
in support of overall expression pattern analysis, either for a single bicluster or for two 
biclusters. 
# heatmap for single bicluster 
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par(mar = c(5, 4, 3, 5) , cex.lab = 1.1, cex.axis = 0.5, cex.main = 1.1
) 
quheatmap(ecoli, res, number = 4)  
Figure 13. Heatmap for the 4th bicluster identified in the E. coli data.  
# heatmap for two biclusters 
par(mar = c(5, 4, 3, 5) , cex.lab = 1.1, cex.axis = 0.5, cex.main = 1.1
) 
quheatmap(ecoli, res, number = c(3,7))  
 
 (viii) We can construct and visualize network for the identified biclusters, using 
the function qunetwork, either for a single bicluster or for two biclusters. 
In the gene co-expression network, each node represents a gene, and a pair of nodes 
is connected with an edge if they have a significant correlation (with the cutoff as 0.6 in 
default). Specifically, for a single bicluster with m genes and n conditions, we used the m-
by-n expression matrix to calculate the correlation between each pair of genes in the 
network. For two given biclusters, whose gene sets are {m1} and {m2} and condition sets 
are {n1} and {n2}, we used the expression matrix, with genes |{m1∪m2}| and conditions 
|{n1∪n2}|, to generate the correlation coefficient scores among genes. QUBICR provides 
three methods to calculate the correlation, i.e., Pearson, Kendall and Spearman, to facilitate 
different preference in practical application. 
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# Construct the network for the 4th identified bicluster in the E.coli 
data 
library(qgraph) 
net1 <- qunetwork(ecoli, res, number = 4, group = 4, method = "spearman
") 
qgraph(net1[[1]], groups = net1[[2]], layout = "spring", minimum = 0.6,
  
color = cbind(rainbow(length(net1[[2]]) -  1), "gray"), edge.label = F) 
 
Figure 14. Network for the 4th bicluster identified in the E. coli data. 
# Construct the network for the 3th and 7th bicluster in the E.coli dat
a 
net2 <- qunetwork(ecoli, res, number = c(3, 7), group = c(3, 7), method
 = "spearman") 
qgraph(net2[[1]], groups = net2[[2]], layout = "spring", minimum = 0.6,
 legend.cex = 0.5, color = c("red", "blue", "gold", "gray"), edge.label
 = FALSE) 
 
 (ix) The function qunet2xml can convert the constructed networks into XGMML 
format, facilitating further functional enrichment analysis (e.g. DAVID) and advanced 
network visualization (e.g. Cytoscape, Biomax and JNets) 
# Output overlapping heatmap XML, could be used in other software such 
# as Cytoscape, Biomax or JNets 
sink("tempnetworkresult.gr") 
qunet2xml(net2, minimum = 0.6, color = c("red", "blue", "gold", "gray")
) 
sink() 
# We can use Cytoscape, Biomax or JNets open file named 
# tempnetworkresult.gr 
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3.3 Summary 
Biclustering algorithms facilitate researchers in the identification of co-expressed 
gene subsets in their gene expression dataset and have become a useful approach for the 
interpretation of gene expression profile data. Our R package implements a well-cited 
biclustering algorithm, QUBIC. It provides more efficient source code and fully integrated 
functions to identify and analyze biclusters and visualize identified biclusters and 
corresponding co-expression networks. This package is a powerful tool for gene expression 
data mining and co-expression network modeling.  
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CHAPTER 4: Application of Biclustering on Biological and Biomedical Data 
The advent of much-improved biotechnology and the decreased associated costs 
have generated a massive amount of biological and biomedical data. NGS allows for 
rapid generation of larger volumes of biological information than ever before. Also, large 
amounts patient clinical data are generated through NGS and Electronic Health Record 
(EHR), which presents significant opportunities for knowledge discoveries in biomedical 
research [119]. These complex and large volumes of data, collected from different 
sources, have changed the way biological and biomedical research is conducted [120, 
121]. Effective utilization and interpretation of such data require advances in 
interdisciplinary sciences. The concept of big-data-to-knowledge relies extensively on 
biological, mathematical, statistical, and computer sciences to extract usable information 
and generate new knowledge. 
Furthermore, with the advancement of informatics technology, EHR contains 
sufficient information that can be transformed into disease phenotypes [122]. In this 
phenotyping process, a heuristic and the iterative searching algorithm is applied to search 
the large-scale EHR database with queries created by clinical experts and knowledgeable 
computational engineers [122], during which thousands of phenotypes generated for all 
the included individuals. These phenotype data can be organized into a matrix, with 
phenotype features as rows and individuals as columns, providing essential materials to 
identify a family of phenotype biclusters. The biclusters define a subgroup of patients 
from a subset of phenotypes, which are subject to detailed validation analysis to establish 
their relations with (i) prognostic or therapeutic characteristics of diseases [123-126], and 
(ii) genotype biclusters [122]. 
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As far as we know, application of biclustering has not progressed in parallel with 
algorithm design. Considering all the biclustering-related publications, the portion of 
application studies has been much lower than that of algorithm development studies from 
the year 2000 to 2017 (Figure 15). This situation is affected by multiple factors. First, there 
is a gap between tool development and the understanding of new biotechnologies and 
corresponding data properties. For example, microarray data is reflecting absolute gene 
expression with continuous fluorescence intensity values [127], while RNA-Seq data 
measures the relative expression level using discrete, positive, and highly skewed read 
counts [88, 128-130]. Furthermore, there are abundant zeros in RNA-Seq-based gene 
expression data as not all the genes are expressed under a specific experimental condition, 
which is particularly true in scRNA-Seq data [82, 131]. Hence, algorithms designed and 
evaluated using microarray data may not be suitable to be directly applied to RNA-Seq 
data. RNA-Seq and scRNA-Seq data need unique design in algorithm and tool 
development. However, contrary to the fact that RNA-Seq is becoming more and more 
popular, few biclustering algorithms are explicitly designed for RNA-Seq data [38, 39, 41, 
42]. Second, there is a knowledge gap for applying biclustering tools and choosing the 
appropriate accompanying analytical tools for specific data analyses. Usually, biclustering 
is not a solo data analysis tool. Instead, it connects with other results annotation processes 
(e.g., DAVID and KOBAS), visualization programs (e.g., Cytoscape), and statistical 
methods (e.g., Principal Component Analysis and Regression Analysis), to derive a more 
comprehensive interpretation. It is worth noting that organically integrating a biclustering 
algorithm and appropriate accompanying tools into a pipeline is not trivial. Construction 
59 
 
of a unified pipeline requires a deeper understanding of underlying algorithm designs, data 
inputs, and expected outputs. 
The yearly proportion of biclustering references related to algorithm development 
and improvement and application studies are presented in Figure 15. The numbers of 
biclustering studies on algorithm design and application were similar at the earliest stage 
when few tools were available. The proportion of application related studies decreased 
relative to algorithm design until 2010. In the 1,650 articles published in 2011, the number 
of studies related to algorithm design was almost nine times that of the application studies. 
Recently, more researchers have realized the biclustering application shortage and made 
significant efforts in this area.  Between 2012 and 2016, the application publication 
proportion increased to 40%. There is still a considerable potential for more application 
related studies; therefore, this review systematically summarizes the basic applications of 
biclustering in biological data and the advanced applications of biclustering in biomedical 
data. This information will enable biological researchers to select appropriate algorithms 
and computational tools for their various studies, effectively bridging the gap between big 
data and valuable biological knowledge and efficiently providing novel data-driven 
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insights. In the following, we will review how biclustering aids biological and biomedical 
data interpretation at the gene, module, and network level, respectively. 
Figure 15. Yearly comparison of biclustering algorithm development and algorithm application 
related studies. The references in 2017 were collected as of 03/26/2017. The overall annual 
reference numbers that shown on the top of each bar were collected by searching the keyword 
"biclustering" on google scholar, and proportion of algorithm development shown in blue was 
captured by adding the keyword "algorithm," and the rest are considered as application related, 
which were shown in orange.  
 
4.1 Basic Application of Biclustering on Biological Data 
It is well known that biological function can rarely be attributed to an individual 
molecule. Instead, most functions arise from complex interactions (as a whole system or 
module) among the cell’s numerous components, such as protein, DNA, RNA, and small 
molecules [132, 133]. Biotechnology has developed very fast in the last two decades, from 
traditional arrays (e.g., microarray and tilling array) to NGS (e.g., DNA-Seq, RNA-Seq, 
and Chip-Seq) to the third-generation long read sequencing (e.g., PACBIO and Oxford 
Nanopore). The generated data provide unprecedented opportunity to understand the 
61 
 
complex biological system at different levels, from basic mutation, gene and protein 
structure level, to pathway/module level, and even global networks. Biclustering analyses 
play a significant role in making sense out of various omics data towards the goal of 
generating a system-level understanding.  
4.1.1 Functional Annotation of Unclassified Genes 
Functional annotation categorizes genes into one or multiple functional classes, 
which is an essential step for understanding the physiological purpose of target/interesting 
genes. However, a reliable functional assessment of a given gene can be carried out only if 
all its interacting genes are known in advance, as a gene can be involved in different 
pathways/networks to achieve specific biological functions [134]. These are typically not 
known for all genes or conditions. Biologists often deal with this challenge, in part, by 
taking advantage of the “guilt-by-association” (GBA) principle. GBA assumes that 
functions can be transferred from one gene to another through biological association. Two 
kinds of information are required for a GBA-based functional annotation: known functional 
annotation in public domain and the associations between annotated and unannotated 
genes. NCBI, Gene Ontology [135], and KEGG [101] are three dominant representatives 
of such comprehensive databases; RegulonDB is one of the most widely-used resources 
for E. coli K-12 gene regulation [102]; The Cancer Genome Atlas (TCGA, 
https://portal.gdc.cancer.gov/) offers genomics, epigenomic and proteomic data for 
thousands of tumor samples across more than 20 types of cancer; and PlantTFDB provides 
comprehensive genomic transcriptional factor (TF) repertoires of green plants [136]. For 
unannotated genes, co-expression is one of the most widely used association indices, as 
gene expression profile collection is accessible and can be used to derive other associations, 
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e.g., co-regulation [137, 138] and co-evolution [139, 140]. Biclustering can be used to 
identify co-expressed genes based on the similarity of their expression profiles across a 
wide range of conditions (e.g., treatments, tissues, and samples), giving rise to a set of 
significant CEMs, i.e., biclusters [141]. Based on existing annotation databases and these 
CEMs, functional enrichment analysis is carried out to identify significantly 
overrepresented functions, using the hypergeometric distribution as a statistical test [99]. 
Highly enriched functions are assumed to be shared by all members in the obtained 
biclusters, and unannotated genes in those biclusters will be assigned to the most abundant 
functional class [142, 143]. It is noteworthy that biclustering is usually combined with the 
comparative genomics strategy in the case of gene annotation for new-sequenced 
organisms, which builds links between well-annotated model organisms and the new 
organisms [144]. 
Despite the high potential of this approach, it is essential to keep in mind that 
correlation does not guarantee causal relationships, i.e., genes with similar expression 
profiles may not have the same function. The results should be interpreted as preliminary 
computational predictions which provide useful hypothesis/candidates for future testing 
[145]. Thus, experimental validation of the predictions is needed. However, the percentage 
of unannotated genes is very high even in well-studied model organisms [93] (e.g., the 
proportion of unannotated genes is around 40-50% in E. coli), and it is unrealistic to go 
through all the to-be-validated candidates exhaustively using experimental methods. 
Therefore, researchers usually just verify functions of a few genes of considerable interest 
[142], and in most cases, they rely on computational validation (e.g., cross-validation [146] 
and random forest [143]) and published literature support.  
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The basic idea of computational validation is to mask the functions of some 
annotated genes in a CEM and check to see if the functions can be correctly assigned back 
to the masked genes. The validation could be conducted by assessing whether the genes 
share conserved sequence motifs, as it is believed that co-expressed genes tend to, although 
not necessarily, be transcriptionally co-regulated [147]. Recently, researchers proposed 
using genome-scale ChIP-Seq data for the validation of the prediction of CEMs [144]. 
Table 5 summarizes five representative studies which inferred the functions of unannotated 
genes from the well-annotated genes that they are co-expressed with. For each of five 
studies, we introduce the input data for the study (Data), biclustering algorithm and 
accompanying analysis methods (Methods), specific tool and software (Tools/Databases) 
used to accomplish the research, the output and results (Outcomes), and related references 
(Refs). All other tables in this study follow the same structure. 
Table 5. Case studies of Functional annotation of unclassified genes 
Data Methods Tools/Databases Outcomes Refs 
Functional annotation of Yeast 
Microarray  
(6,200 ORFs 
under 515 
conditions) 
• Biclustering for gene classification SAMBA 2,406 
biclusters;  
196 annotations 
of unknown 
genes;  
[146] 
• Functionally assign the unannotated genes in 
biclusters to the most abundant class; 
SGD [148] 
• Cross-validation for annotation assessment. - 
Functional annotation of plant genomes 
Microarray  
(21,031 genes 
of Arabidopsis 
under 351 
conditions) 
• Biclustering on known PCW genes;  QUBIC 
417 seed 
biclusters;  
2,438 candidate 
PCW genes co-
expressed with 
349 PCW 
genes. 
[147] 
• Expand biclusters to include additional 
genes; 
QUBIC 
• Construct co-expression network; Cytoscape 
• Predict and annotate motifs in promoter 
regions of co-expressed genes in each 
module. 
WeederTFBS;  
MotifSampler 
CompariMotif 
PLACE 
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AGRIS 
Microarray 
(122,973 
probes of 
Switchgrass, 
94 conditions) 
 
• Homologous mapping of identified CW 
genes; 
Tblastn 
991 homologs 
CW genes;  
104 clusters of 
co-expressed 
genes; 
823 new PCW 
genes;  
112 new genes. 
[144] 
• Assign mapped genes to CW-associated 
functions; 
DAVID 
• Biclustering of mapped genes and expand 
for new candidates; 
QUBIC 
• Identify motifs for each bicluster; - 
• Validate prediction by annotated 
Arabidopsis CW genes 
PCWGD * 
Functional annotation of Human and Mouse 
A correlation 
matrix with 
associations 
among mouse 
lincRNA, 
protein-coding 
genes, and 
lincRNAs 
• Identify lincRNA;  ChIP-Seq Sets of 
lincRNAs 
associated with 
a diverse range 
of functions 
including cell 
proliferation, 
immune 
surveillance, 
muscle 
development, 
etc.. 
[142] 
• Create association matrix of lincRNA and 
protein-coding genes; 
GSEA 
• Biclustering to identify functional modules 
consisting of lincRNAs and protein-coding 
genes; 
SAMBA 
• Assign putative functions to each lincRNA; - 
• Validate inferred biological functions for 
lincRNAs. 
- 
65 human 
microarray 
datasets and 
GO function 
categories 
• Discover network patterns based on frequent 
item sets and biclustering; 
- 
1,126 functions 
assigned to 895 
genes (779 
knowns and 116 
unknowns). 
[143] 
• Design network topology statistic based on 
graph random walk; 
- 
• Assess functional annotation by a random 
forest method. 
- 
Note: - denotes for no specific existed tools and this also applies to all the following tables.  
* Purdue Cell-Wall-Genomics Database (https://cellwall.genomics. purdue.edu) 
 
4.1.2 Modularity Analysis 
Compared to individual cellular components, modularity analysis puts more 
emphasis on the component’s relationship and the topology of a module, i.e., a group of 
physically or functionally linked molecules that work together to achieve distinct functions 
[133]. Increasing evidence indicates that biological systems are inherently modular [149-
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151], therefore, modularity analysis has been widely applied to investigate the organization 
and dynamics of biological systems at different levels, i.e., module identification, module 
dynamic analysis, and module network reconstruction. Up to now, substantial efforts are 
devoted to the first level of modularity analysis, module identification.  
Biclustering has been applied to identify different types of modules, which could 
be groups of interacting molecules (e.g., miRNA sponge modules in [152] and miRNA-
mRNA modules in [153]), functionally related genes/proteins or any other manually 
defined clusters [154]. Depending on the target modules, different inputs and strategies are 
needed. For example, scRNA-Seq gene expression data was utilized to identify molecularly 
distinct subtypes of cells that contribute different brain functions [155]; and an integrated 
correlation matrix was derived from expression data with target site information to predict 
miRNA-mRNA functional modules [153]; time series expression data provides valuable 
information regarding the cellular dynamic activity, thus it is often utilized to identify 
temporal transcriptional modules that consist of activated genes at consecutive time points 
[38]. As various modules are investigated, additional supporting data are often involved. 
For example, promoter sequences and integrated de novo motif detection are integrated 
with co-expression biclustering to identify regulatory modules [61]. Similar strategies have 
been implemented with the integration of other supporting data types (e.g., operon 
prediction, ChIP-Seq data, and network connections) [53].  
With modules identified, further research concentrates on investigating the 
characteristics of modules. Applying functional annotation or enrichment analysis to these 
modules can illustrate/deduce their roles in biological processes [152, 153, 156]. Where 
expression profiles are available in multiple evolutionarily correlated species, researchers 
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can conduct inter-specific comparisons and investigate the underlying evolutionary story. 
For example, Waltman et al. performed biclustering of multiple-species data and then used 
a conservation score to identify conserved modules among these species [157]. Based on 
co-regulation modules, Yang et al. derived an expression-based quantity to characterize 
the functional constraint acting on a gene, and then tested the correlation of those quantities 
with gene Sequence divergence rate to estimate the evolutionary potential of genes [158]. 
With temporal modules, the dynamic regulatory interaction can be explored. Gonçalves et 
al. [159] ranked TFs targeting the modules at each time point and graphically depicted the 
regulatory activity in a module at consecutive time points. Other researchers examined the 
external relationship among modules, e.g., grouped modules of host proteins based on a 
distance measure to form higher-level subsystems [160]. Table 6 summarized four kinds 
of modularity analysis applications, including functional module identification, regulatory 
modules, evolution characteristic, and module subsystem. Module-based network 
inference, as a higher level of modularity analysis, will be introduced in next section.  
Table 6. Case studies of Modularity analysis. 
Data Methods Tools/Databases Outcomes Refs 
Functional Module 
miRNA-mRNA 
regulatory score matrix 
derived from gene 
expression data 
• Create miRNA-mRNA regulatory 
score matrix based on expression 
matrix and miRNA-target binding 
information; 
- 
Four miRNA 
sponge 
modules 
[152] 
• Biclustering on the score matrix to 
infer miRNA-mRNA biclusters; 
BCPlaid 
• Filter biclusters using statistical 
methods and interaction 
information; 
- 
• Functional annotation; GeneCodis 
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• Validation of predicted modules - 
mRNA-miRNA 
association matrix derived 
from gene expression data 
• Construct mRNA-miRNA 
association matrix based on 
expression data and miRNA target 
information;  
- 
100 putative 
miRNA 
functional 
module 
[153] • Biclustering to identify functional 
modules; 
BUBBLE 
• Visualize and evaluate modules. miRMAP 
SC-RNA-Seq (3,005 
mouse cortical cells) 
• Biclustering BackSPIN 
47 distinct 
cell 
subclasses 
[155] 
Regulatory modules 
Microarray data (S. 
cerevisiae under 2,200 
conditions); upstream and 
downstream Sequences. 
• Biclustering COALESCE 
450 
regulatory 
modules 
[61] 
Microarray (M. 
tuberculosis under 2,325 
measurements); and 154 
TFs ChIP-Seq data 
• Biclustering cMonkey2 600 modules [53] 
Time series expression 
for 2,884 genes of 
Saccharomyces cerevisiae 
in response to heat stress 
under five time-points 
• Biclustering CCC-Biclustering 167 
biclusters; 
Regulatory 
snapshots of 
documented 
regulators at 
each time 
point 
[38, 
159] 
• Ranking the prioritize prominent 
regulators targeting each the 
modules at each time point  
Regulatory 
Snapshots 
• Graphically depict the regulatory 
activity in a module  
Baiacu; 
BiGGEsTs 
Evolutionary study 
Three normalized 
expression matrixes (B. 
subtilis, B. anthracis, and 
L. monocytogenes);  
upstream Sequences;  
metabolic and signaling 
pathways, co-membership 
in an operon and 
phylogenetic profile 
networks 
• Biclustering on expression data;  FD-MSCM 
150 biclusters [157] 
• Evaluate the conservation between 
biclusters 
- 
Microarray (4117 
orthologs in 15, 14, and 
• Biclustering to predict co-
regulated modules;  
ISA 
1,181 
modules 
[158] 
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17 tissue groups in rice, 
maize, and Arabidopsis, 
respectively) 
• Quantify the functional constraint 
acting on a gene based on the 
modules (eFC) 
- 
• Correlate eFC with gene Sequence 
divergence rate 
- 
Subsystem 
HIV-1, Human Protein 
Interaction Database 
(HHPID) 
• Biclustering on the binary 
interaction matrix; 
Bimax 279 
significant 
sets of host 
proteins show 
the same 
interaction to 
HIV-1 
[160] 
• Construct bicluster distance 
matrix; 
- 
• Construct neighbor-joining tree 
and designate host subsystem 
- 
4.1.3 Biological Networks Elucidation 
Biological interactions can be conceptualized as networks, with nodes representing 
biological entries and edges denoting relationships between nodes. For example, in protein-
protein interaction (PPI) networks, nodes are proteins and edges represent physical 
interactions; in transcriptional regulatory networks (TRNs), nodes stand for regulators 
(TFs, microRNAs, and lncRNAs) and targets, and edges are regulatory interaction 
directing from regulators to targets. Analyzing these networks provides systematic views 
and novel insights in understanding underlying mechanisms controlling cellular processes. 
Table 7 shows some examples in network analysis, mainly focus on network inference and 
network decomposition. 
Compared with random networks, one distinct characteristic of the biological 
networks is modularity, forming dense subgraphs [161, 162]. Several computational 
approaches have utilized the module-based method to infer networks. For example, in 
TRNs, one widely used approach is to group genes/regulators based on the similarity of 
their expression profile using biclustering, along with the modeling of the regulatory 
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interactions between those modules to get a higher-level understanding of regulatory 
mechanisms[132]. This approach has been successfully applied in several other studies 
[163-165]. On the other hand, Tanay et al. [150] used the hierarchical topology of the 
biological networks. They first used biclustering to identify modules based on integrated 
heterogeneous experimental data, and then built a module graph, with nodes being modules 
and edge connected two modules whenever their genes intersect sufficiently. These small 
modules were clustered into supermodules based on their functional association. In this 
way, a hierarchical transcriptional network was built. It is noteworthy that researchers often 
integrate multiple sources of data, in the hope of getting a more comprehensive and 
accurate view of biological networks. For example, TRNs were constructed using 
expression data as well as Sequence information and interaction data[163-165]; and Tanay 
et al. combined expression data, various interactions, and phenotypes [150]. 
Network decomposition breaks a network down into simpler units or components, 
e.g. network motifs and modules, and is another hotspot in network analysis. Compared 
with the previous modularity analysis section where biclustering method is mainly applied 
to expression data, biclustering takes networks as input in decomposition. Decomposition 
reduces network complexity and facilitates the exploration of the underlying molecular 
mechanisms[166-168]. Henriques and Madeira [35] developed and applied a pattern-based 
biclustering algorithm to discover coherent modules from PPI and showed that most 
modules were significantly enriched with particular biological functions. Lakizadeh et 
al. integrated time series expression data and static PPI networks to extract dynamic PPI 
subnetwork and then detected protein complex based on these subnetworks. They 
concluded that this method could model the dynamicity inherent in static PPI networks. 
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Table 7. Case studies of Biological networks elucidation. 
Inputs Methods Tools/Databases Outputs Refs 
Yeast transcriptional network 
Nearly 1,000 
Saccharomyces cerevisiae 
expression profiles; 110 TF 
binding location profiles; 30 
growth profiles; 1,031 
protein interaction; 4,177 
complex interactions and 
1,175 known interactions 
from MIPS 
• Modeling genomic 
information as weighted graph 
- 
665 
significant 
modules; 
Global Yeast 
molecular 
network 
[150] 
• Biclustering  SAMBA 
• Generate module graph and 
explore associations between 
modules 
 
Methanogenesis regulatory network 
Microarray (1,661 
Methanogen genes under 58 
conditions); 
Upstream regions of all 
genes;  
Operon prediction from 
MicrobesOnline; 
Protein interactions from 
String 
• Biclustering to Identify co-
regulated gene subsets;  
cMonkey 166 
biclusters; 
GRN model 
including a set 
of 1,227 EF 
and TF 
regulatory 
influences that 
inter-link the 
regulation of 
1,661 genes 
[163] 
• Construct GRN to infer 
transcriptional influences of 
each bicluster; 
Inferelator 
• Visualize GRN; 
Cytoscape 
Gaggle 
• Use TF knockout experiment 
and extra data and to validate 
the GRN model  
- 
Mycobacterium tuberculosis regulatory network 
Microarray data 
(Mycobacterium 
tuberculosis genes under 
2,325 conditions);  
Upstream regions of all 
genes;  
~5000 Operon prediction 
from MicrobesOnline;  
~250,000 protein 
interactions from String 
• Biclustering to identify co-
regulated gene subsets;  
cMonkey 
598 
biclusters; 
A global 
regulatory 
network 
covering 98% 
of MTB genes 
[164] 
• Construct GRN model to infer 
transcriptional influences of 
each bicluster; 
Inferelator 
• Validate the GRN model using 
new datasets; Visualize 
Network. 
BioTapestry 
Phaeodactylum tricornutum regulatory network 
RNA-Seq (1,214 
Phaeodactylum tricornutum 
genes from 179 samples); 
Genome annotation, 
Chloroplastic and 
mitochondrial genomic 
information, functional 
annotation, Protein-protein 
interactions 
• Biclustering to identify 
putatively co-regulated genes; 
cMonkey2 
121 biclusters 
covering 
1,214 
metabolic 
genes and TFs 
[165] 
• Construct regulatory network 
to infer regulatory influences; 
Inferelator 
• GO enrichment analysis to 
identify potential biological 
processes carried out by the 
co-regulated genes 
- 
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Biological network decomposition 
Two Gene interaction 
networks for yeast; Two 
PPIs from E. coli and 
human 
• Biclustering BicNET modules with 
heightened 
biological 
significance  
[35] 
• Assess biological significance 
of retrieved modules 
GOrilla 
 
4.2 Advanced Application of Biclustering in Biomedical Science 
A genetic variation that contributes to a specific disease is usually detected 
through single-nucleotide polymorphisms (SNPs), insertion/deletions, variable number 
tandem repeats and copy number variants [169]. Besides, understanding the association 
between above genomic information and specific diseases has led to the discovery of new 
drugs [170].However, the association studies are considered as complicated processes 
because disease risks are attributed to the combined effect of both multiple genetic 
variants and environmental factors. With the increasing application and decreasing cost 
of big data generation techniques in biomedical and health-care informatics, large 
volumes of biological and clinical data sets have become available in the public domain. 
On one hand, this advance provides materials to identify new therapeutic targets, drug 
indications and drug-response biomarkers; on the other hand, it also introduces more 
challenges to the data mining approaches [170]. As the applications of biclustering in 
basic biological science lead to many discoveries and novel methodologies, there is a 
rapidly growing interest in extrapolating it into the big biomedical data. Biclustering is 
deemed as a powerful tool that could identify novel target genes, indicated drugs or 
biomarkers of drug responses, in which the principles of biclustering being used in 
functional annotation and modularity analysis of biological data are also applicable. In 
this section, we provide comprehensive guidance and discuss the applications of 
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biclustering, particularly the integration with other methods, for detecting disease 
subtype, identifying biomarker and gene signatures of disease and gene–drug association. 
4.2.1 Disease Subtype Identification 
Disease subtype could provide a framework for the development of more accurate 
biomarkers by stratification of patient populations [171]. It can be defined by related 
molecular characteristics or clinical features [172]. Gene expression data, depicted as a 
matrix with genes as columns, and subjects as rows (with known or unknown disease 
types), were widely used in molecular subtyping studies. This formulation is reasonable 
because pathways responding to specific disease subtypes may be activated across most 
the patients of the subtype, and the gene expression can be considered candidate 
signatures for subtypes [49]. With benchmark gene expression data sets and well-
annotated disease subtype information, biclustering can discriminate biclusters from the 
gene expression matrix, containing genes that share similar expression patterns only in 
one or some specific subtypes [31, 173]. Hence, denovo identification of biclusters can be 
used to group subjects (patients) into disease subtypes, and these identified patient groups 
can be further evaluated by linking known clinical characteristics [63]. The evaluation 
process assumes that patients from different subtypes tend to have distinctive clinical 
features. In cancer subtyping study, survival time, neoplasm disease stage, tumor size, 
tumor grade, tumor nuclei percentage and patient age have been commonly used to assess 
the subtyping results [33, 117, 118]. Table 8 summed up those application studies in 
certain diseases, including leukemia, gastric cancer, breast cancer, lung cancer, etc. 
For each characteristic, a dependence test, e.g., Chi-square test, is used to examine 
the difference among all subtypes [174, 175]. To be specific, given a clinical characteristic 
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(e.g., the presence of an adverse drug reaction), the null hypothesis of the test is that 
subtypes of a disease and the characteristic are independent, i.e., there are no differences 
among the subtypes regarding that characteristic. After summarizing the frequencies or 
counts of cases under different subtypes into a 𝑟 ×   contingency table ( 𝑟 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑜𝑤𝑠,  = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓  𝑜𝑙𝑢𝑚𝑛𝑠), the Chi-square test statistic is calculated by 
using the formula: 
𝜒2 = ∑
(𝑂 − 𝐸)2
𝐸
 
where 𝑂 represents the observed frequency, 𝐸 represents the expected frequency 
under the null hypothesis, which is computed by: 
𝐸 =
𝑟𝑜𝑤 𝑡𝑜𝑡𝑎𝑙 ×  𝑜𝑙𝑢𝑚𝑛 𝑡𝑜𝑡𝑎𝑙
 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒 
 
The test statistics will be compared to the critical value of 𝜒𝛼
2 (𝑑𝑓 = (𝑟 −
1) × ( − 1)). If 𝜒2 > 𝜒𝛼
2 , the null hypothesis will be rejected, meaning that there are 
differences among subtypes regarding that characteristic (see details in Example S1). 
Meanwhile, interpretation of the identified biclusters in gene dimension can be carried out, 
more details of biomarker and gene signatures detection can be found in the next section.  
Table 8. Case studies of disease subtype identification. 
Data  Methods  Tools/Databases Outcomes  Refs 
Leukemia 
Microarray data with 
12,533 probes from 72 
patients of different 
subtypes of leukemia 
• Biclustering by qualitative 
biclustering algorithm 
QUBIC 
Biclusters with 
cancer subtyping 
information 
[31] 
Gastric cancer 
74 
 
Microarray data for 80 
paired gastric cancer and 
reference tissues from 
non-treated patients 
• Biclustering on gene 
expression data for bicluster 
identification; 
QUBIC [31]; 
Pathways 
associated with 
cancer 
development; 
identified gastric 
cancer subtypes 
[176] 
• Pathway enrichment analysis. 
DAVID [177] 
KOBAS [178] 
HPID [179] 
Breast cancer 
Microarray data with 
7756 genes and matched 
clinical data for 437 
primary breast tumor 
patients 
• Adjust for cohort-correlated 
batch effect across the non-
adjuvant treated tumor data 
set; 
ComBat [180] 
Similar clinical 
features 
associated with 
tumor within the 
same cluster 
[181] • Biclustering to identify 
molecular-based tumor 
subgroup; 
cMonkey [52] 
• Determine molecular 
classifiers for each bicluster; 
PAM [182] 
Microarray data with 
17,814 genes across 547 
samples 
and gene network 
consisted of 11,648 
genes and 211,794 
interactions 
• Assign weights to genes 
based on impact in the 
network and expression 
variation;  
PageRank [183] 
Cancer subtypes [63] 
• Weighted biclustering 
algorithm based on a semi-
nonnegative matrix tri-
factorization. 
NCIS [63] 
Colon and lung cancers 
290 colon cancer 
samples, each has 384 
methylation probes 
covering 151 cancer-
specific differentially 
methylated region 
(cDMRs);  
Expression levels of 
12,625 genes in 56 
patients having lung 
cancer 
• Heterogeneous sparse singular 
value decomposition 
(HSSVD) based Biclustering 
- 
Variance 
biclusters of 
methylation data 
in cancer versus 
normal patients 
using colon 
cancer data; 
cancer subtype 
patterns using 
lung cancer data 
[173] 
 
4.2.2 Biomarker and Gene Signatures Detection 
Biclustering proved to be influential for mining information from elaborate 
biomedical data sets, especially in cancer research. Cancer is complicated because of the 
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heterogeneity of tumor cells and is recognized as a system-level disease [184, 185]. 
Biclustering has been used with human gene expression data to identify cancer subtype 
patterns [31, 63, 173, 181, 186], metabolic pathways highly related to cancer 
progression[176], marker genes of a specific cancer type/subtype [8, 155], and clinical 
risk factors of cancer [187]. Also, studies of common or rare diseases have used 
biclustering of human gene expression data to identify phenotype-genotype associations 
[188, 189], dysregulated transcription modules [190], and genetic risk variants [191]. 
Depending on the available information, various levels of analyses can be conducted as 
summarized below. 
Basically, given gene expression matrix with rows representing genes and 
columns representing patients, biclustering can identify co-expressed gene clusters that 
are specific to characteristics of patients, e.g. certain subtypes or disease stages. If genes 
included in the identified biclusters have differential expression patterns between 
different subtypes, then they can serve as candidate gene signatures or biomarkers for 
cancer staging and subtyping [176]. If predefined gene sets are given, and clinical 
characteristics/phenotype labels are also available, researchers can carry out gene set 
enrichment analysis (GSEA) first to investigate the correlation between gene sets and 
clinical characteristics/covariates (e.g. tumor grade, stage, age or hormone status). Based 
on these correlations results, a binary association matrix can be derived, with rows 
representing gene sets and columns representing pairwise tests for phenotypes, the 
element ‘1’ denoting significant association between gene set and pairwise test, and ‘0’ 
denoting no significant association. Biclusters identified from this association matrix can 
represent modules that associated with known clinical covariates [187]. 
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A matrix of SNPs or phenotypes and the extended matrices from them, including 
a matrix of regression coefficients of SNPs associated with traits and matrix of P-values 
of SNPs in traits, were subjected to biclustering to recognize the phenotype–genotype 
connections [188, 189, 191]. With the developments of RNA-Seq, whole transcriptomic 
data are becoming available to characterize and quantify gene expression [192]. The 
recent advent of scRNA-Seq technology has enabled researchers to study heterogeneity 
between individual cells and define cell type a based solely on its transcriptome [8]. 
Using biclustering, researchers can not only group cells into subpopulations but also 
identify biologically important gene signatures for each class simultaneously [193]. For 
example, Zeisel et al. [155] recently classified single cells from the brain through 
biclustering, which identified numerous marker genes and highly restricted expression 
patterns of transcription factors for cell types. Kiselev et al. [8] developed a stable and 
accurate consensus tool, based on such scRNA-Seq data, which can quantify the inherent 
heterogeneity of single cells, define the subclonal composition and identify marker genes. 
Meanwhile, new biclustering applications are emerging, such as detecting disease marker 
genera from gut biome [194]. The gut microbiome is typically tricky to profile and use of 
biclustering enhances identification of specific taxonomic signatures that can support the 
elucidation of disease risk [194]. 
These identified biclusters were subjected to downstream analysis of functional 
gene annotation [186, 188], gene network inference  [188] or phenomic analysis [188, 
189, 191]. Most of the gene functional annotations were done through the UCSC Genome 
Browser [195]. Gene networks among clustered genes were commonly constructed by the 
Ingenuity Pathways Analysis software developed by QIAGEN. Phenomic analysis 
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performs pairwise genetic correlation of traits/phenotype against gene sets identified by 
biclustering, which is usually done using hypergeometric statistics or paired t-
test. Table 9 gives an overview of biomarker/gene signature identification studies, with 
the detailed procedures regarding biclustering and accompanied analyses specified in the 
column ‘Methods’. It is noteworthy that the application of biclustering in these 
biomedical studies is much more complicated compared with those in basic biological 
applications, regarding the data sources, data preprocessing methods and downstream 
statistical analyses. 
Table 9. Case studies of Biomarker and gene signatures detection. 
Data Methods Tools/Databases Outcomes Refs 
Breast cancer 
Association matrix of 
1,008 gene expression 
microarray profiles of 
primary breast tumors  
• Biclustering binary data matrix. iBBiG 
Modules 
associated 
with clinical 
covariates in 
breast cancer 
[187] 
Matrix of normalized 
miRNA Sequencing 
expression profiles 
• Biclustering to evaluate miRNA 
deregulation; 
ISA[100] 
12 different 
miRNA 
clusters 
[186] 
• Validate each bicluster by an external 
repository of different groups of 
miRNAs in human species; 
MetaMirClust 
[196] 
UCSC [195] 
• Compare results with a different 
biclustering algorithm. 
SAMBA [146] 
Osteoporosis 
Regression coefficients 
matrix of 1,109 unique 
SNPs associated with 
23 studied traits from 
the GWAS data of 
the Framingham 
Osteoporosis Study 
• GWAS database mining; Tagger [197] SNP-
phenotype 
connections; 
Highly 
genetically 
correlated 
traits; 
Candidate 
genes 
identified for 
[188] 
• Biclustering on matrix of SNPs against 
phenotypes; 
Bayesian 
biclustering 
[198] 
• Gene annotation and identification of 
enriched canonical pathway and gene 
network inference. 
UCSC [199] 
IPA 
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multiple bone 
traits 
Williams-Beuren syndrome 
Normalized skin 
fibroblast microarray 
dataset including 9,329 
probe sets and 96 
samples 
• Identify transcriptional modules; ISA[100] 
72 
dysregulated 
modules were 
found 
[190] • Test modules containing at least ten 
genes for dysregulation using 
hypergeometric distribution. 
- 
Schizophrenia 
8,023 subjects, 4,196 
patients, and 3,827 
controls, with 2,891 
SNPs in each subject 
• Perform biclustering for both 
phenotype and genotype data; 
bioNMF [62] 
Causally 
cohesive 
genotype-
phenotype 
relations 
[189] 
• Cross-correlate phenotype and 
genotype biclusters; 
- 
• Organize and encode relations into 
topologically organized networks; 
PGMRA [189] 
• Estimate genotype associated disease 
risk. 
SKAT[200] 
Complex diseases 
p-value matrix of 
466423 SNPs in 32 
independent 
diseases/traits 
• Identify biclusters of diseases/traits 
and SNPs 
SparseBC [201] 
Genetic risk 
variants for 
complex 
diseases 
[191] 
LAS [57] 
SSVD [202] 
• Map detected SNPs to genes - 
4.2.3 Gene-drug Association 
In drug development, it is vital to understand the complicated responses in the 
human body to various drug treatments [203, 204]. However, rigorous testing of safety 
and efficacy of novel drug makes drug development time-consuming, expensive and 
often unsuccessful. Alternatively, computational drug repositioning is termed as an 
efficient way to identify new applications for current medicines [205]. By the 
advancement of biotechnologies, a significant amount of gene expression data becomes a 
paramount component in characterizing the human responses to drugs. Here, we review 
the applications of biclustering in the context that is considered appropriate in revealing 
the co-expression patterns encompassed in the drug-perturbed responses [206]. The 
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genome-scale drug-treated gene expression data were served as raw materials for 
identification of co-expression modules using biclustering methods, where different drug 
treatments were conditions. Table 10 gave an overview of four typical studies that were 
examining the drug-induced co-expression modules. In these studies, information for 
both gene and drug members was mined to characterize the detected drug-induced 
modules. Conservation of identified biclusters was first evaluated across data sets through 
overlapping genes and drugs [206]. Then, genes and drugs in the bicluster were 
examined, respectively. Functional enrichment of these genes was tested using the 
DAVID knowledge base to determine the biological relevance of these biclusters [206, 
207]. Enrichment of drug annotation terms can be assessed by various databases, such as 
STRING [208] and DAVID [177], for identification of transcriptional factors linked to 
these biclusters [206, 209, 210]. 
Table 10. Case studies of gene-drug association. 
Data Methods Tools/Databases Outcomes Refs 
Drug-gene associations 
NCI-60 cancer cell 
line in drug 
response; 
Gene expression 
data 
• Identify co-modules of drugs and genes; PPA [207] 859 co-
modules were 
identified, and 
drug-gene 
associations 
were 
predicted 
more 
accurately 
than other 
algorithms 
[207] 
• Test drug-gene association. 
DrugBank [211] 
Connectivity Map 
[212] 
Drug-Induced Transcriptional Modules 
6,100 gene 
expression profiles 
of human cancer 
cell treated with 
1,309 small 
• Biclustering drug‐induced gene 
expression profiles [100]; 
ISA [50] 
Drug-induced 
transcriptional 
modules 
[206] • Hypergeometric test for significance 
assessment of overlaps among gene 
members; 
- 
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molecules from 
CMap [212]; 
1,743 expression 
profiles from liver 
tissues of drug-
treated rats [213]. 
• Predict novel gene functions by 
comparing modules of human cancer and 
rat liver cell lines; 
STRING [208] 
• Test enriched gene functions and 
identified biological themes among 
transcriptional modules. 
DAVID [177] 
Transcriptional factors (TFs) for drug-associated gene modules 
7,056 genome-wide 
expression profiles 
of five different 
human cell lines 
treated with 1,309 
chemical agents at 
different dosages 
from CMap [212] 
• Identify drug-gene modules by 
biclustering method; 
FABIA [32] 
Links 
between 28 
modules with 
12 TFs were 
detected 
[209] 
• Indicate Gene Ontology (GO) and Kyoto 
Encyclopedia of Genes and Genomes 
(KEGG) information associated with 
genes in modules;  
DAVID [110] 
• Use cumulative hypergeometric test to 
evaluate drug target enrichment. 
- 
Transcriptomics and decision in early-stage of pharmaceutical drug discovery 
Transcriptomic 
profiles in eight 
drug discovery 
projects of 
oncology, virology, 
neuroscience and 
metabolic diseases. 
• Normalize and filtrate mRNA expression 
data; 
- 
Transcription
al effects of 
compounds 
[210] 
• Identify transcriptional modules; FABIA [32] 
• Identify transcriptional modules related 
to the desired effect using target-related 
bioassay measurements. 
PSVM [214] 
 
4.3 Summary 
GBA is the basis of expression profile-based biclustering; however, co-expression 
does not guarantee co-regulation. One popular strategy to further elucidate co-regulation 
is to integrate supporting data that provide evidence of co-regulation with expression 
data, e.g. motif prediction and network connection. In support of a more comprehensive 
clarification of complex biological systems in a cell, existing biological network 
inference tools should embed multiple regulatory signals, e.g. TF, lncRNAs and 
miRNAs, and organically integrate biclustering within their network construction 
framework. Use of these methods and integration of well-annotated phenotypic data can 
enhance the identification of CEM and improve systems-level insights. Combination of 
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biclustering of gene expression and clinical phenotype data with successive enrichment 
analyses has revealed disease subtype patterns and diseases biomarkers. Biclustering has 
contributed to drug development by exposing the co-expression patterns from the drug-
treated gene expression data. Most uses of biclustering in biomedicine to date rely on a 
handful of conventional biclustering algorithms, as it remains unclear which are 
sufficiently accurate for any given data type. 
A workflow of biclustering application is proposed here to integrate the methods 
and tools used in both biological and biomedical fields discussed above. As shown 
in Figure 16, there are three layers (Data, Methods and Results) in this workflow. The 
data sources in the first layer provide the information directly collected and derived from 
genotyping and phenotyping results. Different method combinations in layer two can be 
used for various analytical requirements. Biclustering can be used to analyze phenotype 
matrix, genotype matrix, as well as the derived association matrix of these two matrices. 
A few example tools were shown in the figure for biclustering methods. These 
biclustering methods are often accompanied by downstream analysis, such as functional 
annotation, module analysis or network construction, to interpret the identified biclusters, 
together with statistical evaluation tools applied to demonstrate bicluster associations. 
Examples of results from a combination of the methods identified in layer two provide 
specific illustrations of corresponding outputs results [31, 181, 215-217]. The 
connections between data and methods offer model analysis paths for researchers to use 
depending on the characteristics of their data. 
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Figure 16. The overall workflow of biclustering application mechanism related to upstream and 
downstream process. Three layers are shown to provide the path from raw data, appropriate 
analytical methods/tools to various cases of the result. The power of biclustering is illustrated by 
the ability to generate co-expressed gene modules, subtype or biomarker, regulatory networks, 
clinical entities and estimated disease-free survival (DFS) distribution. 
The identified workflow guides many current studies; however, new 
biotechnologies are developing and emerging rapidly, while the corresponding 
biclustering tools are not evolving at a parallel pace. This situation is an important factor 
limiting the application of biclustering analysis to more complex data sets, e.g. 
multidimensional biological image data, requiring integration of multiple variables. 
Meanwhile, considering the variety and complexity of data from various platforms, the 
data integration and analyses are not trivial, and it is more challenge to combine multiple 
required computational techniques with biclustering analysis. Furthermore, different data 
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types may need specifically designed biclustering algorithms. For example, scRNA-Seq 
data exhibit higher heterogeneity than RNA-Seq data and are increasing in popularity; 
however, few biclustering algorithms are explicitly designed for these new data. Hence, 
additional biclustering methods, which include specific design attributes taking the 
characteristics of biological and biomedical data into account, are still needed to facilitate 
larger-scale applications of biclustering. 
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APPENDIX 2: Data Links 
The link for all the datasets used in the thesis is provided in Table11. 
Table 11. Data links 
Data Link Note 
E. coli RNA-Seq http://bmbl.sdstate.edu/downloadFiles/E.coli%20RNA-seq/ Include expression 
matrix and five sets 
of pathways 
Simulation data http://bmbl.sdstate.edu/downloadFiles/simulation/ Include expression 
matrix and ten 
groups of modules 
TCGA data https://zenodo.org/record/1157938#.W489C_ZFwiQ  
scRNA-Seq data https://scrnaSeq-public-datasets.s3.amazonaws.com/manual-
data/yan/nsmb.2660-S2.csv 
Used in 2.3 and 2.5.  
GSE52583 http://www.cs.cmu.edu/~jund/scdiff/download/data/treutlein2014  
mouse olfactory bulb 
scRNA-Seq data 
http://www.spatialtranscriptomicsresearch.org/wp-
content/uploads/2016/07/Rep2_MOB_count_matrix-1.tsv 
MOB Replicate2 
GSE 48968 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE48968  
GSE60402 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60402  
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APPENDIX 3: Citation Map for QUBIC 
The citation map for QUBIC (including QUBIC algorithm, Qserver and QUBICR) is provided in Figure 17. 
 
Figure 17. Citation map for QUBIC 
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APPENDIX 5: Curriculum Vitae 
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